Biological medication for rheuma

RX_RHEUMA_BIOLOGICAL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L04AA24\|L04AC03\|L04AB04\|L04AB01\|L04AB06\|L04AB02\|L04AB05\|L04AA26\|L01XC02\|L04AC10\|L04AC07\|L04AC05 1 out of 7 registries used, show all original rules.	9205
4. Check minimum number of events Min. number of events 3	9205
5. Include endpoints None	9205
6. Filter based on genotype QC (FinnGen only)	8481

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_RHEUMA_BIOLOGICAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L04AA24\|L04AC03\|L04AB04\|L04AB01\|L04AB06\|L04AB02\|L04AB05\|L04AA26\|L01XC02\|L04AC10\|L04AC07\|L04AC05
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Biological medication for rheuma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27308	15324	11931
Only index persons	26669	14962	11707
Unadjusted period prevalence (%)
Whole population	0.39	0.44	0.33
Only index persons	0.50	0.55	0.45
Median age at first event (years)
Whole population	45.20	45.96	44.26
Only index persons	45.68	46.51	44.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8481	5235	3246
Unadjusted period prevalence (%)	1.72	1.86	1.49
Median age at first event (years)	48.75	48.85	48.59

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8789: Matched controls
87890

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AC16

ATC

guselkumab; systemic

44.4

322.3

191

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

41.5

310.6

187

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

27.9

307.7

982

395

K51.5

ICD-10 Finland

Left sided colitis

13.3

307.7

1190

1025

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

28.7

307.7

1348

551

H02AB07

ATC

prednisone; oral

4.5

307.7

2055

5583

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

29.9

307.7

479

169

3029

Kela drug reimbursment

Upadacitinib

102.3

307.7

363

UJF32

NOMESCO Finland

Coloscopy

3.4

307.7

3094

11963

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

56.7

307.7

6430

4033

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

23.0

307.7

1378

705

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

23.9

307.7

1259

611

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

17.9

307.7

319

185

M06

ICD-10 Finland

Other rheumatoid arthritis

28.7

307.7

286

103

293

Kela drug reimbursment

Baricitinib

132.4

307.7

232

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

51.9

307.7

397

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.5

307.7

5689

25375

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

17.8

307.7

383

224

L40.0

ICD-10 Finland

Psoriasis vulgaris

8.8

307.7

1274

1655

H02AB06

ATC

prednisolone; systemic

9.5

307.7

7213

28540

P01BA02

ATC

hydroxychloroquine; oral

17.9

307.7

3406

3002

3042, ,

Kela drug reimbursment

39.9

307.7

241

256, ,

Kela drug reimbursment

1142.8

307.7

435

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.4

307.7

959

2393

L04AX03

ATC

methotrexate; systemic

62.3

307.7

6406

3635

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

10.6

307.7

607

611

L04AB01

ATC

etanercept; parenteral

1830.4

307.7

3238

L04AA24

ATC

abatacept; parenteral

2682.5

307.7

769

D05AX52

ATC

calcipotriol, combinations; topical

7.2

307.7

1293

2067

ZX120

NOMESCO Finland

Intravenous

6.4

307.7

1890

3617

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

979.3

307.7

6108

204

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

22.0

307.7

353

167

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

23.1

307.7

249

111

XX9XE

NOMESCO Finland

Other ultrasound examination

17.4

307.7

368

220

L04AC18

ATC

risankizumab; parenteral

39.9

307.7

203

A02BC02

ATC

pantoprazole; systemic

2.6

307.7

6452

45642

A07EC02

ATC

mesalazine; oral, rectal

11.1

307.7

1955

2204

L01BA01

ATC

methotrexate; systemic

59.3

307.7

2951

743

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.4

307.7

726

1448

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

10.7

307.7

570

564

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.2

307.7

2322

4821

L01BB02

ATC

mercaptopurine; oral

22.7

307.7

766

368

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

28.2

307.7

670

256

3006

Kela drug reimbursment

Baricitinib

114.0

307.7

244

K50.0

ICD-10 Finland

Crohn disease of small intestine

21.7

307.7

902

461

L40.5

ICD-10 Finland

Arthropathic psoriasis

30.5

307.7

1044

387

M01CB01

ATC

sodium aurothiomalate; parenteral

56.1

307.7

807

158

M45

ICD-10 Finland

Ankylosing spondylitis

34.0

307.7

1502

530

K50.9

ICD-10 Finland

Crohn disease, unspecified

21.9

307.7

822

412

L88

ICPC

Rheumatoid/seropositive arthritis

35.2

307.7

2706

1098

D05AX02

ATC

calcipotriol; topical

9.2

307.7

875

1040

UJF30

NOMESCO Finland

Ileoscopy through colon

4.9

307.7

1949

4864

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

307.7

2474

11057

L04AB04

ATC

adalimumab; parenteral

3140.6

307.7

5005

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

31.3

307.7

340

113

L04AB06

ATC

golimumab; parenteral

9944.6

307.7

1647

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

13.9

307.7

407

306

L04AA17

ATC

[U] adalimumab

634.4

307.7

424

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

5.2

307.7

1884

4404

A07EA06

ATC

budesonide; oral, local oral

15.7

307.7

1729

1354

298, ,

Kela drug reimbursment

135.2

307.7

363

3005

Kela drug reimbursment

Tofacitinib

84.3

307.7

317

L04AA01

ATC

[U] ciclosporin

22.8

307.7

654

309

NH3EA

NOMESCO Finland

Feet X-ray examination with load

11.8

307.7

670

609

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

11.1

307.7

1112

1133

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.4

307.7

1174

2457

M13.9

ICD-10 Finland

Arthritis, unspecified

7.3

307.7

1879

3169

K50.8

ICD-10 Finland

Other Crohn disease

26.6

307.7

1028

435

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

12.3

307.7

343

289

M07.3

ICD-10 Finland

Other psoriatic arthropathies

33.5

307.7

645

207

K50.1

ICD-10 Finland

Crohn disease of large intestine

21.4

307.7

664

334

L04AA11

ATC

[U] etanercept

302.0

307.7

512

UJF92

NOMESCO Finland

Capsular endoscopy

7.7

307.7

560

773

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.7

307.7

4699

14685

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

10.7

307.7

700

708

K51.8

ICD-10 Finland

Other ulcerative colitis

11.8

307.7

511

456

253, ,

Kela drug reimbursment

40.6

307.7

241

M01CB03

ATC

auranofin; oral

31.3

307.7

297

4AA12, ,

NOMESCO Finland

42.7

307.7

293

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

25.6

307.7

345

140

A07EA02

ATC

hydrocortisone; rectal

9.7

307.7

607

666

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

16.1

307.7

515

339

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

30.0

307.7

579

206

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

31.5

307.7

2812

1294

L04AX01

ATC

azathioprine; systemic

19.5

307.7

2248

1522

L04AB05

ATC

certolizumab pegol; parenteral

9788.2

307.7

892

4AB02, ,

NOMESCO Finland

51.9

307.7

325

L04AA44

ATC

[U] upadacitinib

125.3

307.7

208

L04AA37

ATC

[U] baricitinib

118.7

307.7

220

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

17.1

307.7

673

424

ZX140

NOMESCO Finland

Intra articular

17.8

307.7

316

184

L04AC07

ATC

tocilizumab; parenteral

3003.2

307.7

583

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

458.6

307.7

2043

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

16.9

307.7

2345

1850

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

37.6

307.7

406

113

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

11.2

307.7

515

485

L04AF03

ATC

upadacitinib; oral

67.3

307.7

299

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

22.7

307.7

639

303

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

8.6

307.7

681

849

NG1DA

NOMESCO Finland

X-ray of knees

9.3

307.7

399

448

NDG30

NOMESCO Finland

Fusion of wrist, total

32.7

307.7

273

L04AA29

ATC

[U] tofacitinib

113.4

307.7

359

D07XC01

ATC

betamethasone; topical

3.6

307.7

1659

5291

291

Kela drug reimbursment

Tofacitinib

122.6

307.7

319

A07EC01

ATC

sulfasalazine; oral, rectal

46.1

307.7

5156

2627

L04AC13

ATC

ixekizumab; parenteral

183.9

307.7

437

L04AD01

ATC

ciclosporin; systemic

12.5

307.7

684

591

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

45.0

307.7

211

WZA10

NOMESCO Finland

Extensive medical or dental certificate

18.3

307.7

654

384

D05AX03

ATC

calcitriol; topical

13.7

307.7

386

293

L04AK01

ATC

leflunomide; oral

24.4

307.7

361

154

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

57.0

307.7

596

112

L04AC05

ATC

ustekinumab; parenteral

750.8

307.7

939

L04AB02

ATC

infliximab; parenteral

876.0

307.7

939

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

29.9

307.7

473

167

TNG10

NOMESCO Finland

Puncture of knee

25.2

307.7

594

252

L04AA13

ATC

[U] leflunomide

64.5

307.7

2197

452

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

13.8

307.7

331

249

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

22.1

307.7

394

186

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

26.7

307.7

3896

2544

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1130.2

307.7

5930

161

L04AC10

ATC

secukinumab; parenteral

2160.7

307.7

829

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

51.1

307.7

414

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

28.8

307.7

282

101

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

26.5

307.7

3605

2251

D05BB02

ATC

acitretin; oral

9.2

307.7

563

647

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

13.3

307.7

660

533

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

13.2

307.7

736

603

H20.1

ICD-10 Finland

Chronic iridocyclitis

14.5

307.7

360

259

M01AH01

ATC

celecoxib; oral

3.0

307.7

2019

7861

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

7.2

307.7

945

1445

R4120

NOMESCO Finland

Occupational therapy

3.9

304.5

986

2764

NDL52

NOMESCO Finland

Tenosynovectomy of hand

18.0

304.2

246

140

K50

ICD-10 Finland

Crohn disease [regional enteritis]

23.0

300.2

218

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

10.0

299.6

346

358

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

27.7

299.4

203

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

48.1

292.2

170

E0000UV, ,

ATC

2.2

292.0

4456

27624

WZC30

NOMESCO Finland

Teaching

2.7

290.9

1885

7981

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

72.6

290.8

157

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.6

289.2

419

575

D94

ICPC

Chronic enteritis/ulcerative colitis

12.7

288.9

283

229

L04AA32

ATC

apremilast; oral

28.5

283.2

190

D07AD01

ATC

clobetasol; topical

2.6

277.0

1971

8722

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

33.7

274.8

175

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

274.4

2776

14426

N02AX02

ATC

tramadol; systemic, rectal

2.2

273.0

4082

24891

D07AC01

ATC

betamethasone; topical

2.2

265.5

3710

21958

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

40.7

264.5

160

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

261.3

4485

28700

L04AG05

ATC

vedolizumab; parenteral

30.2

261.3

172

L04AC14

ATC

sarilumab; systemic

657.4

260.0

256

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

37.9

259.7

160

L04AC21

ATC

bimekizumab; systemic

72.7

251.9

136

M05BA04

ATC

alendronic acid; oral

3.9

251.2

789

2156

L40.8

ICD-10 Finland

Other psoriasis

13.2

246.3

236

184

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

245.0

1382

5405

M01AC06

ATC

meloxicam; systemic, rectal

2.1

242.1

3417

20121

L04AA33

ATC

[U] vedolizumab

37.9

241.8

149

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

35.7

241.2

151

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

6.8

234.2

374

570

NF1AA

NOMESCO Finland

Hip X-ray examination

3.5

234.2

883

2725

K51

ICD-10 Finland

Ulcerative colitis

8.6

232.9

301

360

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

21.6

231.2

172

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

5.0

228.0

508

1062

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

9.7

227.4

267

282

RT272, ,

NOMESCO Finland

26.5

226.6

156

M01AH05

ATC

etoricoxib; oral

2.1

226.1

6126

45483

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

15.6

224.2

195

128

M13.0

ICD-10 Finland

Polyarthritis, unspecified

8.8

223.2

284

333

L01CB

ATC

Podophyllotoxin derivatives

68.1

221.8

121

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

6.0

218.0

395

684

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.1

216.3

1034

3678

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.6

215.5

542

1251

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

7.3

212.3

316

446

S91

ICPC

Psoriasis

9.7

210.5

248

263

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

9.1

209.3

259

293

L40.9

ICD-10 Finland

Psoriasis, unspecified

7.0

208.6

324

479

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

204.8

3661

23139

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.1

204.8

592

1519

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

28.5

201.4

135

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

9.9

200.5

232

240

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

10.5

196.0

217

211

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

193.4

4335

29414

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.2

192.2

846

2861

C10AC01

ATC

colestyramine; oral

4.9

191.1

440

944

134

Kela drug reimbursment

General erythroderma

20.3

188.6

144

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

45.0

187.9

111

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

35.9

187.2

117

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

186.8

848

2918

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

186.3

1018

3883

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.9

184.7

930

3393

H02AB08

ATC

triamcinolone; systemic

26.3

184.2

127

M25.5

ICD-10 Finland

Pain in joint

1.9

184.1

3491

22297

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

12.2

181.9

182

152

WW200

NOMESCO Finland

Immunization

4.5

181.0

456

1052

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

13.4

179.2

169

128

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

6.3

179.1

305

496

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

16.3

178.3

151

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

47.4

176.4

103

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

9.7

175.9

207

219

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

175.4

4101

27913

R4180

NOMESCO Finland

Podiatric therapy

7.7

174.6

246

326

M19.2

ICD-10 Finland

Other secondary arthrosis

7.6

173.5

249

337

JF1AD

NOMESCO Finland

Small bowel CT

11.8

171.3

175

151

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

21.3

168.4

126

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.5

168.0

1192

5166

J01MA02

ATC

ciprofloxacin; systemic

1.9

167.3

3245

20714

H02AB04

ATC

methylprednisolone; systemic

2.3

167.0

1435

6778

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

17.1

166.8

138

S01BA04

ATC

prednisolone; ophthalmic

5.9

166.0

302

524

RT271, ,

NOMESCO Finland

31.2

165.9

108

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

9.5

164.4

196

211

L04AF01

ATC

tofacitinib; oral

52.2

162.5

NDF10

NOMESCO Finland

Synovectomy of wrist

44.1

161.7

L40

ICD-10 Finland

Psoriasis

5.0

160.7

353

727

M01AH02

ATC

rofecoxib; oral

2.6

158.5

1050

4398

WVA20

NOMESCO Finland

Medicine administration

4.4

158.0

411

971

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

157.0

3151

20237

L04AF02

ATC

baricitinib; oral

83.8

156.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.8

156.2

891

3463

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

16.7

155.4

130

R4110

NOMESCO Finland

Physiotherapy

1.9

154.5

2510

15037

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

22.7

153.7

112

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

6.7

152.8

244

371

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

11.4

152.1

159

142

E000001, ,

ATC

2.0

152.0

2035

11393

9522

FHL

Synovectomy

35.6

151.5

S01BA01

ATC

dexamethasone; ophthalmic

4.1

150.8

426

1071

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

149.6

814

3084

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

39.5

147.6

J01FF01

ATC

clindamycin; systemic

1.9

147.3

2538

15459

A02BC03

ATC

lansoprazole; oral

1.9

146.9

2346

13935

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

16.4

145.7

123

NH3AE

NOMESCO Finland

Feet ultrasound examination

17.5

145.5

119

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

37.5

144.0

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

45.2

143.9

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

28.5

143.2

J01DB01

ATC

cefalexin; oral

2.2

142.7

7563

64735

L20

ICPC

Joint symptom/complaint NOS

3.5

141.7

520

1565

M17.5

ICD-10 Finland

Other secondary gonarthrosis

6.3

141.6

240

388

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

6.0

139.2

250

428

M08.8

ICD-10 Finland

Other juvenile arthritis

68.8

137.5

WX002

NOMESCO Finland

Sedation and analgesia

2.1

136.6

1607

8545

ZX112

NOMESCO Finland

Subcutaneous

5.0

136.0

297

608

TQW80

NOMESCO Finland

Local dermatologic skincare

4.3

135.5

356

847

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

135.1

3353

22704

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

10.5

134.2

148

143

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

22.0

132.9

D07AC13

ATC

mometasone; topical

1.8

132.8

2641

16726

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

36.0

131.2

9256

FHL

Synovectomy (knee 9311)

36.0

131.2

SPAT1202

SPAT

Intra-articular injection

4.6

130.9

316

703

N02BE01

ATC

paracetamol; systemic, rectal

2.3

130.8

7862

68913

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

9.6

130.8

154

163

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

128.9

1656

9074

RK220, ,

NOMESCO Finland

14.7

128.8

115

NHG22

NOMESCO Finland

Fusion of subtalar joint

10.3

128.7

144

142

JF1BD

NOMESCO Finland

Very extensive small bowel CT

11.9

128.0

130

111

M05BA07

ATC

risedronic acid; oral

5.2

127.7

267

526

M01AE02

ATC

naproxen; oral, rectal

1.7

127.5

5314

41300

R50.9

ICD-10 Finland

Fever, unspecified

2.0

125.7

1516

8112

M13.8

ICD-10 Finland

Other specified arthritis

6.8

125.1

197

295

L73.2

ICD-10 Finland

Hidradenitis suppurativa

5.6

123.5

237

432

M01AX01

ATC

nabumetone; oral

3.6

123.5

433

1264

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

123.3

946

4218

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

122.9

2154

13067

L34

ICPC

Musculoskeletal, Blood test

43.3

122.4

Z3226

NOMESCO Finland

Physiotherapist

2.0

122.0

1602

8829

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

6.6

121.6

197

304

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.2

121.2

330

806

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

20.0

121.1

P01AB01

ATC

metronidazole; oral, rectal

1.7

119.4

3631

25763

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

12.0

119.2

120

101

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.3

117.9

463

1452

ZZH31

NOMESCO Finland

Bone allograft, small pieces

9.8

115.5

134

139

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

27.7

113.8

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

113.6

593

2189

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

32.0

112.9

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

5.4

112.6

224

422

NF1DA

NOMESCO Finland

X-ray of hips

5.0

112.5

245

500

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

111.9

949

4411

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.5

111.5

395

1160

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

109.5

1194

6130

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.1

108.7

234

473

M01AB55

ATC

diclofenac, combinations; oral

2.9

108.5

531

1892

WX320

NOMESCO Finland

Spinalanesthesy

1.8

107.8

1976

12084

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

6.9

107.7

167

246

299, ,

Kela drug reimbursment

23.5

107.2

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.3

106.9

425

1342

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

4.1

106.0

303

767

Z3231

NOMESCO Finland

Registered nurse

1.8

105.7

2297

14753

NDG76

NOMESCO Finland

Fusion of DIP joint

7.6

105.3

150

201

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

104.3

2655

17804

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

25.9

103.9

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

26.5

103.2

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

6.2

103.2

179

296

L99

ICPC

Musculoskeletal disease other

4.0

103.2

298

760

A02BC05

ATC

esomeprazole; systemic

1.6

102.7

3392

24314

D05AA

ATC

Tars

9.7

102.2

119

124

S18

ICPC

Laceration/cut

1.6

102.0

3839

28407

K07.60

ICD-10 Finland

Snapping jaw

2.5

101.8

673

2794

E000003, ,

ATC

2.9

101.2

497

1773

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

100.2

3405

24538

M05BX04

ATC

denosumab; parenteral

3.0

98.4

469

1645

9284

FHL

Wrist ossification surgery

44.9

97.9

E000002, ,

ATC

2.0

97.6

1135

5951

M01CC01

ATC

penicillamine; oral

39.6

96.7

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

23.2

95.5

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

47.0

95.5

B01AB05

ATC

enoxaparin; parenteral

1.7

95.3

2344

15502

J05AB11

ATC

valaciclovir; oral

1.9

95.2

1369

7721

4AA24, ,

NOMESCO Finland

54.3

94.8

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

11.8

94.5

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

242.6

93.7

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

15.8

93.2

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

22.9

90.9

4AA33, ,

NOMESCO Finland

22.9

90.9

A04AA01

ATC

ondansetron; systemic, rectal

2.3

90.5

762

3518

RT171, ,

NOMESCO Finland

19.6

90.3

WX204

NOMESCO Finland

Axillary plexus blockaced

3.1

90.1

383

1258

D07AB08

ATC

desonide; topical

2.0

89.1

1032

5392

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

35.2

88.9

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

17.7

88.7

A02BC01

ATC

omeprazole; systemic

1.7

88.6

2095

13666

M05BA06

ATC

ibandronic acid; systemic

5.2

87.5

181

353

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

87.5

1935

12388

ND1AE

NOMESCO Finland

Wrist ultrasound examination

11.3

87.2

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

87.1

456

1682

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

19.0

86.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

86.0

2752

19362

NDG74

NOMESCO Finland

Fusion of first IP joint

17.0

85.8

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

9.4

85.1

101

108

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.5

84.9

302

888

D02AE01

ATC

carbamide; topical

2.4

84.6

625

2725

H02AB09

ATC

hydrocortisone; systemic

3.4

84.5

311

935

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.9

84.4

189

395

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.1

84.2

148

248

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

84.0

1203

6755

K60.3

ICD-10 Finland

Anal fistula

3.9

83.8

255

675

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

27.3

83.7

ZXE00

NOMESCO Finland

One hour or less

1.6

83.5

3188

23344

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.4

82.5

301

900

R2110

NOMESCO Finland

Giving the first information

2.3

82.4

685

3142

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

82.3

665

3014

M16.7

ICD-10 Finland

Other secondary coxarthrosis

6.8

81.5

127

188

S01FA04

ATC

cyclopentolate; ophthalmic

5.9

81.4

147

253

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

6.2

81.3

140

230

M06.3

ICD-10 Finland

Rheumatoid nodule

24.9

81.0

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.6

80.9

476

1863

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.7

79.2

254

697

RT310, ,

NOMESCO Finland

22.4

79.2

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.3

78.8

209

500

M06.1

ICD-10 Finland

Adult-onset Still disease

32.1

78.8

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

14.7

78.4

M01AX17

ATC

nimesulide; oral

1.7

78.1

1633

10256

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

77.9

1964

12966

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.2

77.5

671

3128

QDH05

NOMESCO Finland

Correction of deformity of toe nail

10.9

77.3

NHG82

NOMESCO Finland

Fusion of other tarsal joint

6.2

77.3

132

215

D05AX05

ATC

tazarotene; topical

22.5

76.6

NHG20

NOMESCO Finland

Fusion of talocrural joint

7.5

76.5

110

149

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

76.2

2167

14731

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.6

76.1

252

707

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

28.5

75.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

75.5

475

1921

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

9.2

75.1

100

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

17.5

74.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

74.6

705

3402

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

74.2

927

4958

ZXA00

NOMESCO Finland

Right side

1.7

74.0

1785

11628

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

73.9

1823

11945

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

33.7

73.7

ZY010

NOMESCO Finland

Hospital outpatient

2.2

73.5

627

2903

R5120

NOMESCO Finland

Preparation of an aid

3.6

73.5

246

695

RK210, ,

NOMESCO Finland

12.8

73.4

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

73.2

2706

19530

SPAT1325

SPAT

Vaccination

1.6

73.1

2319

16157

J01CA04

ATC

amoxicillin; systemic

1.7

73.1

7395

66343

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

73.0

651

3069

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

72.9

1960

13118

N03AX16

ATC

[U] pregabalin

1.7

72.4

1780

11644

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

72.1

507

2158

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.7

71.8

169

368

JFB20

NOMESCO Finland

Ileocaecal resection

7.6

71.5

101

134

H05AA02

ATC

teriparatide; parenteral

10.1

70.8

D06BB04

ATC

podophyllotoxin; topical

2.2

70.7

639

3028

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

70.7

637

3015

318

Kela drug reimbursment

Teriparatide

9.4

70.6

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

70.4

1072

6116

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

7.1

70.1

105

149

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

23.9

70.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

69.6

3288

24947

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

69.4

6375

55385

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

3.6

69.3

234

665

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

69.0

250

744

XQ848

NOMESCO Finland

Dermatological photography

3.1

68.4

288

940

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

14.6

68.1

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

67.8

507

2218

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.8

67.4

208

556

JFB00

NOMESCO Finland

Partial resection of small intestine

4.7

67.0

156

337

Z2221

NOMESCO Finland

Medical doctor

1.6

66.8

2231

15675

J01MA12

ATC

levofloxacin; systemic

1.7

66.6

1289

7887

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

7.3

66.3

134

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

9.4

66.2

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

9.3

65.7

JHA00

NOMESCO Finland

Anal or perianal incision

3.8

64.6

200

536

ND2CG

NOMESCO Finland

Extensive MRI of hand

9.8

64.2

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

28.8

64.1

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

28.8

64.1

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

6.2

64.1

110

180

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

19.3

64.1

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

63.9

1668

11034

H20

ICD-10 Finland

Iridocyclitis

6.2

63.3

109

179

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

9.4

63.3

TNF10

NOMESCO Finland

Puncture of hip joint

16.0

63.2

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

63.1

245

761

SPAT1153

SPAT

Removal of sutures

1.6

63.1

2195

15526

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

15.4

63.1

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

23.8

62.8

M25.4

ICD-10 Finland

Effusion of joint

4.0

62.8

178

448

3AC01, ,

NOMESCO Finland

5.0

62.8

134

269

ZXA05

NOMESCO Finland

Left side

1.6

62.6

1621

10698

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

62.5

1137

6827

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

7.8

62.4

111

4AC07, ,

NOMESCO Finland

214.9

62.2

1XC02, ,

NOMESCO Finland

6.8

62.1

144

M66.0

ICD-10 Finland

Rupture of popliteal cyst

4.6

62.0

150

334

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

62.0

2470

17981

L88

ICD-10 Finland

Pyoderma gangrenosum

11.5

62.0

ZXX08

NOMESCO Finland

Extent of procedure, 8 units

20.5

61.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

61.4

320

1176

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

61.4

1032

6053

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

61.1

756

4019

A02BB01

ATC

misoprostol; oral

9.0

61.0

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.2

61.0

100

M46.0

ICD-10 Finland

Spinal enthesopathy

17.3

60.9

9283

FHL

Subtalar joint ossification surgery (or triple)

26.4

60.8

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.7

60.5

348

1345

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.5

60.4

383

1553

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

9.5

60.3

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

27.5

60.2

L40.1

ICD-10 Finland

Generalized pustular psoriasis

27.5

60.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

59.9

1157

7059

NDG71

NOMESCO Finland

Arthrodes of first MP joint

9.8

59.8

Z01.2

ICD-10 Finland

Dental examination

1.4

59.7

4368

35731

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

59.6

722

3809

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

10.6

59.4

Z50.1

ICD-10 Finland

Other physical therapy

2.4

59.4

430

1853

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.5

59.2

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

11.8

59.2

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

8.3

59.0

E000007, ,

ATC

2.2

58.9

528

2490

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

58.9

555

2670

M12.3

ICD-10 Finland

Palindromic rheumatism

11.1

58.8

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.1

58.2

581

2857

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

15.7

58.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

58.0

1708

11602

TEG00

NOMESCO Finland

Punction of mandibular joint

14.0

57.8

H26.3

ICD-10 Finland

Drug-induced cataract

6.2

57.6

159

K61.0

ICD-10 Finland

Anal abscess

3.3

57.6

226

707

M02.8

ICD-10 Finland

Other reactive arthropathies

6.5

57.3

144

A07AA09

ATC

vancomycin; oral

4.3

57.0

150

357

D02AX

ATC

Other emollients and protectives

2.7

56.9

326

1257

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

8.8

56.9

E000006, ,

ATC

2.1

56.9

556

2711

J01FA10

ATC

azithromycin; systemic

1.4

56.8

5249

44629

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

56.8

1065

6439

J02AC01

ATC

fluconazole; systemic

1.4

56.7

3363

26374

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.4

56.4

112

211

L04AC03

ATC

anakinra; parenteral

+∞

56.3

L40.4

ICD-10 Finland

Guttate psoriasis

6.5

55.6

142

M79.7

ICD-10 Finland

Fibromyalgia

2.5

55.6

377

1577

P01BA01

ATC

chloroquine; systemic

8.7

55.5

A02BA02

ATC

ranitidine; systemic

1.7

55.1

1203

7578

M01AB01

ATC

indometacin; systemic, rectal

2.3

55.0

429

1909

A46

ICD-10 Finland

Erysipelas

1.8

54.9

993

5938

N03AX12

ATC

[U] gabapentin; oral

1.7

54.9

1233

7824

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandibular joint with high intensity magnet

16.5

54.7

S97

ICPC

Chronic ulcer skin

2.3

54.5

417

1841

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

7.9

54.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

54.3

356

1466

J01AA02

ATC

doxycycline; systemic

1.5

54.2

6243

55029

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.2

54.0

467

2169

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.8

53.9

167

448

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

53.3

1133

7080

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

52.8

606

3134

S01FA02

ATC

scopolamine; ophthalmic

5.6

52.7

177

B02.9

ICD-10 Finland

Zoster without complication

2.1

52.5

509

2473

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

52.1

3575

28652

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

74.4

52.0

RF410, ,

NOMESCO Finland

4.3

52.0

133

310

J05AB01

ATC

aciclovir; systemic

1.5

51.8

1766

12359

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.2

51.7

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

10.4

51.7

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

51.6

356

1500

RJ421, ,

NOMESCO Finland

9.1

51.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

51.5

462

2177

L17

ICPC

Foot/toe symptom/complaint

1.5

50.8

2444

18334

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

8.2

50.8

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

50.8

194

597

M05BA01

ATC

etidronic acid; systemic

10.4

50.8

JFH11

NOMESCO Finland

Laparoscopic colectomy

17.9

50.7

Z71.8

ICD-10 Finland

Other specified counselling

1.4

50.7

3030

23665

RF120, ,

NOMESCO Finland

4.3

50.6

129

300

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

50.5

3112

24431

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

50.5

2719

20829

H15.1

ICD-10 Finland

Episcleritis

3.3

50.0

190

583

WZA00

NOMESCO Finland

Concise certificate

1.9

50.0

640

3436

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

11.7

49.8

NC1AE

NOMESCO Finland

Elbow ultrasound examination

11.7

49.8

9531

FHL

Arthrodesis of the hand joint

10.6

49.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

49.6

5100

43662

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

10.1

49.5

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

4.3

49.5

129

305

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

48.8

523

2638

NGF10

NOMESCO Finland

Total synovectomy of knee, open

12.0

48.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

48.8

321

1324

L01BB01, ,

ATC

12.4

48.7

RJ410, ,

NOMESCO Finland

8.1

48.6

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.0

48.5

103

206

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

48.2

335

1417

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.1

48.1

451

2163

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.6

48.0

295

1178

SPAT1251

SPAT

Organisation of medication

2.8

47.9

243

880

L28

ICPC

Limited function/disability (L)

1.6

47.9

1111

7091

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

47.8

2325

17442

M01AB08

ATC

etodolac; oral

2.0

47.8

558

2902

RJ512, ,

NOMESCO Finland

14.4

47.6

RT350, ,

NOMESCO Finland

14.4

47.6

9269

FHL

Other measure in this category

13.8

47.6

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.4

47.3

168

494

RJ411, ,

NOMESCO Finland

6.5

47.1

120

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.0

46.8

216

743

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.1

46.4

197

646

TGC00

NOMESCO Finland

Bronchial lavation

3.1

46.4

200

662

RS221, ,

NOMESCO Finland

3.5

46.4

163

476

ZXA10

NOMESCO Finland

Bilateral

1.6

45.9

1207

7940

RJ511, ,

NOMESCO Finland

11.5

45.6

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

45.4

228

822

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

12.2

45.3

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

6.0

45.2

132

R06AE07

ATC

cetirizine; oral

1.4

45.1

3815

31420

A07EA01

ATC

prednisolone; oral, rectal

6.4

45.1

116

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

45.0

201

679

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

44.8

367

1666

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.3

44.7

114

265

SPAT1255

SPAT

Intravenous administration of medicine

2.0

44.6

482

2437

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

44.5

767

4512

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

44.3

6342

56824

M02AA07

ATC

piroxicam; topical

1.4

44.3

2336

17739

NBF15

NOMESCO Finland

Humeroscapular synovectomy, arthroscopic

10.1

44.2

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.6

44.0

267

1059

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

43.8

302

1272

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

43.8

318

1371

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

43.6

716

4151

H57.1

ICD-10 Finland

Ocular pain

2.1

43.5

406

1942

SFA10

NOMESCO Finland

One-surface restoration

1.4

43.5

4934

42477

M05.0

ICD-10 Finland

Felty syndrome

57.0

43.4

H02BX01

ATC

methylprednisolone, combinations; systemic

2.4

43.0

301

1277

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

7.6

42.8

R01AD12

ATC

fluticasone furoate; nasal

1.4

42.8

2930

23253

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

8.3

42.7

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

10.7

42.6

RF420, ,

NOMESCO Finland

3.6

42.5

139

387

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

42.5

433

2143

WX402

NOMESCO Finland

General anaesthesia

1.5

42.4

1877

13780

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

42.3

1984

14721

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

42.2

703

4092

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

42.2

4556

38837

J01FA06

ATC

roxithromycin; oral

1.4

42.0

2961

23592

M15.3

ICD-10 Finland

Secondary multiple arthrosis

8.9

41.9

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

41.8

596

3310

K02.1

ICD-10 Finland

Caries of dentine

1.4

41.5

5413

47456

NDG20

NOMESCO Finland

Fusion of wrist, partial

5.8

41.3

130

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.2

41.1

108

257

SFA20

NOMESCO Finland

Two-surface restoration

1.4

41.1

5238

45723

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

41.0

1525

10804

M03BX02

ATC

tizanidine; oral

1.4

40.9

5282

46182

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

9.3

40.9

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.4

40.9

281

1182

4AC05, ,

NOMESCO Finland

211.0

40.9

QDH

NOMESCO Finland

Operations on toe nails

16.0

40.9

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

5.0

40.5

172

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

40.4

255

1031

9272

FHL

Metatarsophalangeal joint resection

10.3

40.4

M35.7

ICD-10 Finland

Hypermobility syndrome

2.9

40.4

187

645

ZX114

NOMESCO Finland

Intramuscular

3.3

40.2

154

475

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

40.2

735

4393

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.2

40.1

159

501

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

10.8

39.9

Z93.2

ICD-10 Finland

Ileostomy status

6.8

39.8

RT274, ,

NOMESCO Finland

10.0

39.8

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

9.1

39.5

J01FA09

ATC

clarithromycin; systemic

1.4

39.5

2563

20098

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

39.4

570

3179

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.6

39.2

228

887

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

13.3

39.1

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

39.0

6487

58790

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

10.0

38.9

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

5.0

38.9

167

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

38.9

1893

14113

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.1

38.8

403

2007

RK120, ,

NOMESCO Finland

8.8

38.4

J04BA02

ATC

dapsone; oral

5.5

38.2

133

255, ,

Kela drug reimbursment

195.8

37.8

3048, ,

Kela drug reimbursment

195.8

37.8

R1250

NOMESCO Finland

Evaluation of functional capability

2.6

37.6

217

841

WW200, ,

SPAT

1.4

37.4

2195

16892

M79.6

ICD-10 Finland

Pain in limb

1.3

37.2

3584

29819

M02AA10

ATC

ketoprofen; topical

1.6

37.1

1096

7381

RS222, ,

NOMESCO Finland

3.7

36.7

116

316

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

36.7

386

1932

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.5

36.6

128

373

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

36.6

454

2408

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

14.4

36.5

NCK10

NOMESCO Finland

Partial or total excision of bone of elbow or forearm, other location

10.9

36.4

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

4.2

36.4

238

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

36.4

467

2505

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

36.2

1080

7284

ND2BG

NOMESCO Finland

MRI of hand

6.4

36.1

SPAT1204

SPAT

Arthrocentesis

5.1

36.1

151

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

9.6

35.9

H26.2

ICD-10 Finland

Complicated cataract

3.6

35.9

119

335

B01AB10

ATC

tinzaparin; parenteral

1.7

35.8

773

4827

M02.3

ICD-10 Finland

Reiter disease

10.9

35.5

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

35.3

439

2330

R06.0

ICD-10 Finland

Dyspnoea

1.4

35.3

1804

13535

ACC51

NOMESCO Finland

Release of median nerve

1.8

35.0

596

3486

A01

ICPC

Pain general/multiple sites

1.7

35.0

758

4736

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

6.0

34.4

100

R03AC02

ATC

salbutamol; inhalant

1.3

34.4

4545

39392

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

34.4

794

5041

SPAT1301

SPAT

No procedures

1.4

34.3

2154

16721

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

39.3

34.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

34.2

780

4935

TJF80

NOMESCO Finland

Ostomy education

4.0

34.1

250

M01AE52

ATC

naproxen and esomeprazole; oral

2.3

33.8

258

1137

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.4

33.7

232

977

H30.2

ICD-10 Finland

Posterior cyclitis

6.8

33.4

-1, ,

NOMESCO Finland

1.3

33.4

2895

23602

J01CF05

ATC

flucloxacillin; systemic

1.7

33.3

603

3588

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

33.1

310

1485

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

33.0

1852

14095

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

3.1

33.0

136

439

Z22.30

ICD-10 Finland

Latent tuberculosis

35.2

32.7

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

32.7

788

5054

J01DA01

ATC

[U] cefalexin

1.3

32.6

4828

42359

N02BF01

ATC

gabapentin; oral

1.6

32.6

808

5217

L15

ICPC

Knee symptom/complaint

1.4

32.5

1910

14643

R60.0

ICD-10 Finland

Localized oedema

1.6

32.5

792

5090

RT160, ,

NOMESCO Finland

8.1

32.4

N06AX21

ATC

duloxetine; oral

1.5

32.4

982

6637

SPAT1263

SPAT

Sampling

1.3

32.4

3164

26213

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

32.3

409

2182

SPAT1229

SPAT

Assessment of need for aid

1.9

32.3

404

2147

ZX100

NOMESCO Finland

Oral

3.5

32.3

111

320

M16.6

ICD-10 Finland

Other secondary coxarthrosis, bilateral

7.5

32.2

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

8.3

32.1

M09.0*L40.5

ICD-10 Finland

Juvenile arthritis in psoriasis

61.9

32.0

SFA30

NOMESCO Finland

Three-surface restoration

1.3

31.9

3407

28562

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.1

31.9

135

443

M01AH03

ATC

valdecoxib; oral

1.9

31.8

420

2272

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.9

31.8

236

TQW40, ,

SPAT

1.6

31.7

753

4808

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

31.6

757

4844

J04AB02

ATC

rifampicin; systemic

3.6

31.2

104

294

A07EC03

ATC

olsalazine; oral

8.2

31.2

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.8

31.2

161

590

D09AB01

ATC

zinc bandage without supplements; topical

2.9

31.1

151

535

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.1

31.1

285

1354

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.8

31.1

161

591

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

3.3

31.1

117

358

RT172, ,

NOMESCO Finland

11.5

30.9

JHD20

NOMESCO Finland

Incision of fistula-in-ano

3.4

30.9

110

325

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

30.8

198

808

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

30.8

1531

11395

NH1AD

NOMESCO Finland

Ankle and foot CT

2.3

30.8

227

986

L95

ICPC

Osteoporosis

2.3

30.7

227

988

K83.0

ICD-10 Finland

Cholangitis

3.3

30.6

118

366

RJ190, ,

NOMESCO Finland

9.5

30.6

NDL99

NOMESCO Finland

Other operation on muscle or tendon of wrist or hand

7.6

30.5

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.7

30.5

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

30.4

2301

18331

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

30.3

1011

6971

S10

ICPC

Boil/carbuncle

1.8

30.2

485

2788

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

3.6

30.1

268

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.9

30.1

140

485

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

30.1

362

1900

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

30.0

1856

14327

K92.1

ICD-10 Finland

Melaena

2.1

29.9

304

1503

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

29.9

1022

7081

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

12.0

29.9

N06AA09

ATC

amitriptyline; systemic

1.7

29.7

583

3546

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

7.5

29.7

L04AA45

ATC

[U] filgotinib

155.5

29.7

B07.9

ICD-10 Finland

Verruca simplex

2.0

29.6

352

1839

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.6

29.5

167

642

Z2446

NOMESCO Finland

Social worker

1.7

29.3

535

3190

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.6

29.3

278

M48.0

ICD-10 Finland

Spinal stenosis

1.7

29.2

625

3886

4AA17, ,

NOMESCO Finland

+∞

29.2

WVA30, ,

SPAT

1.8

29.1

478

2765

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.5

29.1

184

746

R11

ICD-10 Finland

Nausea and vomiting

1.6

29.0

687

4383

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.7

29.0

161

613

S01ED01

ATC

timolol; ophthalmic

2.6

28.9

171

671

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

28.9

820

5458

K71

ICPC

Rheumatic fever/heart disease

28.0

28.8

R01AD09

ATC

mometasone; nasal

1.3

28.8

3850

33106

RJ420, ,

NOMESCO Finland

5.8

28.8

NBB10

NOMESCO Finland

Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified

5.8

28.8

SDA03

NOMESCO Finland

Periodontal treatment

1.3

28.7

3541

30129

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.0

28.7

127

428

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

28.7

1168

8374

B02

ICD-10 Finland

Zoster [herpes zoster]

2.0

28.5

333

1729

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

28.4

1467

10975

OAB93, ,

SPAT

1.6

28.4

730

4748

S21

ICPC

Skin texture symptom/complaint

1.5

28.4

1081

7648

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

28.3

245

1138

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

28.3

848

12249

ZXD05

NOMESCO Finland

Urgent procedure

1.3

28.2

2173

17322

S01BC03

ATC

diclofenac; ophthalmic

2.6

28.2

159

610

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

28.1

326

1689

R5110, ,

SPAT

1.7

28.1

511

3044

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

4.8

28.0

133

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

27.2

27.9

M54.5

ICD-10 Finland

Low back pain

1.3

27.9

3015

25187

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

10.7

27.8

JFF10

NOMESCO Finland

Loop enterostomy

4.8

27.7

130

S01EA05

ATC

brimonidine; ophthalmic

3.0

27.7

122

410

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.4

27.7

184

764

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

27.5

3284

27773

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

27.5

4655

41133

N02AA05

ATC

oxycodone; systemic

1.5

27.4

925

6387

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

27.2

144

535

-50

ICPC

Medication/prescr/renewal

2.1

27.2

262

1270

J01MA14

ATC

moxifloxacin; systemic

1.6

27.1

597

3740

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

26.9

779

5202

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

26.9

724

4759

R01AD58

ATC

fluticasone, combinations; nasal

1.3

26.8

2292

18524

S01ED51

ATC

timolol, combinations; ophthalmic

1.9

26.7

353

1910

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

26.7

158

621

M01AB05

ATC

diclofenac; systemic, rectal

1.3

26.7

5226

46939

S01EC01

ATC

acetazolamide; systemic

2.7

26.6

138

507

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.7

26.6

141

524

RK250, ,

NOMESCO Finland

5.0

26.5

112

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

26.3

1813

14193

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

26.2

214

971

M79.1

ICD-10 Finland

Myalgia

1.4

26.2

1244

9159

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

26.2

561

3488

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

5.2

26.2

102

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

5.2

26.2

102

1222

FHL

Arthroscopy and synovial surgery

3.5

26.2

265

D07AA02

ATC

hydrocortisone; topical

1.4

26.2

1126

8146

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

25.8

26.1

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

5.9

26.0

G47.3

ICD-10 Finland

Sleep apnoea

1.4

25.9

1732

13491

UJF02

NOMESCO Finland

Peroral enteroscopy

4.5

25.8

142

JFH10

NOMESCO Finland

Total colectomy and ileostomy

7.0

25.8

JFA60

NOMESCO Finland

Stricturoplasty in small intestine

93.7

25.6

RJ210, ,

NOMESCO Finland

6.5

25.5

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.2

25.4

218

1011

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.7

25.3

134

498

9527

FHL

Alloarthroplasty, implant or endoprosthesis

28.4

25.3

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.6

25.3

146

567

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

25.2

181

778

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

25.1

4741

42236

C08CA01

ATC

amlodipine; oral

1.3

25.1

2088

16779

A07AA02

ATC

nystatin; oral

1.9

25.1

338

1842

SBB10

NOMESCO Finland

Dental impressions

1.6

25.0

631

4082

L04AF04

ATC

filgotinib; oral

+∞

25.0

252, ,

Kela drug reimbursment

+∞

25.0

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

25.0

113

386

R01AD08

ATC

fluticasone; nasal

1.3

25.0

2304

18780

ZXC50

NOMESCO Finland

Cryotherapy

2.5

25.0

152

606

N02BF02

ATC

pregabalin; oral

1.6

24.9

531

3297

RF210, ,

NOMESCO Finland

2.2

24.9

214

992

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.4

24.8

173

735

5550A

ICD-9 Finland

Regional enteritis, Small intestine

23.4

24.7

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.8

24.7

127

465

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

24.6

578

3676

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

43.0

24.5

WX290

NOMESCO Finland

Other blockage of nerve

1.3

24.5

4383

38752

B01AB04

ATC

dalteparin; parenteral

1.9

24.4

326

1772

SPAT1260

SPAT

Consultation of another employee

1.4

24.3

1160

8544

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.2

24.2

206

951

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

24.2

375

2132

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

24.1

212

992

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

24.1

371

2106

NHK68

NOMESCO Finland

Shortening or lengthening osteotomy of ankle or foot

5.7

24.1

NH3CG

NOMESCO Finland

Extensive MRI of foot

3.5

24.0

236

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

24.0

1689

13235

L11

ICPC

Wrist symptom/complaint

1.5

24.0

790

5421

3053, ,

Kela drug reimbursment

+∞

24.0

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

24.0

808

5571

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

24.0

308

1653

M02.1

ICD-10 Finland

Postdysenteric arthropathy

5.8

23.9

C07AB07

ATC

bisoprolol; oral

1.3

23.8

2708

22653

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

67.6

23.8

1370

FHL

Colonoscopy, whole colon

5.1

23.7

L04AA14

ATC

[U] anakinra

240.6

23.6

-44

ICPC

Preventive immunization/medic

1.7

23.6

456

2760

EC1VA, ,

NOMESCO Finland

1.7

23.6

401

2343

R4190

NOMESCO Finland

Nutritional therapy

1.8

23.6

347

1943

SAA04

NOMESCO Finland

Special examination of mouth

1.7

23.5

426

2533

5551A

ICD-9 Finland

Regional enteritis, Large intestine

23.7

23.4

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

23.3

2306

18938

4AB0M, ,

NOMESCO Finland

46.8

23.3

S01BA07

ATC

fluorometholone; ophthalmic

2.6

23.3

130

497

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

23.2

321

1764

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.0

23.2

159

JFF13

NOMESCO Finland

Terminal enterostomy

6.5

23.0

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

9.1

22.9

S01FA06

ATC

tropicamide; ophthalmic

9.1

22.9

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

22.9

1892

15157

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

22.9

3852

33711

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

22.8

905

6438

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

22.8

663

4428

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

65.1

22.8

R06AX27

ATC

desloratadine; oral

1.3

22.8

2555

21307

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

22.8

941

6746

L12

ICPC

Hand/finger symptom/complaint

1.4

22.8

1382

10581

A98

ICPC

Health maint/preventive medicine

2.2

22.7

8626

84377

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

22.6

397

2340

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

22.5

1059

7773

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

22.4

2906

24656

NDG79

NOMESCO Finland

Other excision, reconstruction or fusion of joint of II-V finger

8.8

22.4

L52

ICD-10 Finland

Erythema nodosum

3.5

22.3

219

R05

ICD-10 Finland

Cough

1.3

22.2

1590

12475

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

2.5

22.2

142

580

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

22.2

455

2798

RJ412, ,

NOMESCO Finland

7.3

22.0

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

6.1

22.0

B80

ICPC

Iron deficiency anaemia

2.1

21.9

204

977

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.4

21.8

156

670

R51.80

ICD-10 Finland

Headache

1.4

21.8

1325

10138

K05.30

ICD-10 Finland

Periodontitis complex

1.4

21.7

1036

7620

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.2

21.7

175

792

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

18.4

21.7

D05AC01

ATC

dithranol; topical

20.1

21.6

UJG02

NOMESCO Finland

Proctoscopy

2.3

21.6

156

673

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

21.5

1020

7494

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

21.5

777

5430

M50.8

ICD-10 Finland

Other cervical disc disorders

4.2

21.4

138

S20

ICPC

Corn/callosity

2.5

21.4

128

507

L84

ICD-10 Finland

Corns and callosities

2.0

21.3

233

1185

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

21.2

480

3025

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

6.8

21.2

B35.3

ICD-10 Finland

Tinea pedis

1.7

21.1

379

2250

NB1AD

NOMESCO Finland

Shoulder CT examination

2.6

21.1

119

458

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

21.0

196

939

L60.0

ICD-10 Finland

Ingrowing nail

1.7

21.0

378

2244

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

4.3

21.0

123

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.0

21.0

213

1054

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.7

21.0

112

419

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

20.9

100

353

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

20.9

2549

21428

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

20.9

419

2562

4AB0X, ,

NOMESCO Finland

60.1

20.9

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

20.8

710

4901

RS121, ,

NOMESCO Finland

3.7

20.8

181

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

20.8

108

398

A05AA02

ATC

ursodeoxycholic acid; oral

2.3

20.8

159

704

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

3.9

20.7

159

QDB10, ,

SPAT

2.2

20.7

164

737

H02AB02

ATC

dexamethasone; systemic

0.6

20.7

279

4898

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

20.7

831

5924

NDM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of wrist or hand

3.9

20.6

155

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

3.8

20.6

164

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

20.6

1388

10782

L16

ICPC

Ankle symptom/complaint

1.4

20.6

956

6995

M09.0

ICD-10 Finland

Juvenile arthritis in psoriasis

110.3

20.6

A03

ICPC

Fever

1.3

20.5

1558

12311

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

20.5

927

6751

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

20.4

2908

24873

TNX10, ,

SPAT

3.1

20.4

283

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

20.4

536

3501

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

20.4

197

958

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

7.5

20.3

B01AX06

ATC

[U] rivaroxaban

2.6

20.3

113

432

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

20.3

1977

16156

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

20.3

170

782

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

20.2

1294

9974

9260

FHL

Alloarthroplasty, endoprosthesis or implant

48.1

20.1

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

20.1

277

1521

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

20.1

357

2113

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.2

20.1

170

785

ZZH40

NOMESCO Finland

Substitute of bone

3.3

20.0

230

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

2.8

20.0

340

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.8

20.0

324

1869

9289

FHL

Other measure in this category

18.8

19.9

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.6

19.9

115

448

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

4.3

19.8

116

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.7

19.8

104

386

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

5.2

19.8

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

35.8

19.8

5BA08, ,

NOMESCO Finland

4.5

19.8

104

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

19.7

776

5509

M07.2

ICD-10 Finland

Psoriatic spondylitis

73.6

19.7

H221, M083,

ICD-10 Finland

73.6

19.7

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

2.6

19.6

110

422

M05BX03

ATC

strontium ranelate; oral

5.3

19.6

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.1

19.6

182

872

K61.1

ICD-10 Finland

Rectal abscess

4.6

19.6

101

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

7.7

19.5

S01

ICPC

Pain/tenderness of skin

1.7

19.5

329

1919

L13

ICPC

Hip symptom/complaint

1.4

19.5

1166

8889

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

40.2

19.5

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.7

19.5

100

367

7168A

ICD-9 Finland

Other and unspecified arthropathies, Other specified arthropathy

21.6

19.4

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

19.4

1282

9922

H16.9

ICD-10 Finland

Keratitis, unspecified

2.3

19.4

147

649

L30.3

ICD-10 Finland

Infective dermatitis

1.9

19.3

259

1410

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

19.3

1339

10441

M31.6

ICD-10 Finland

Other giant cell arteritis

6.3

19.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

19.2

1405

11039

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

19.1

101

376

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

19.0

1315

10245

H20.8

ICD-10 Finland

Other iridocyclitis

3.7

19.0

160

S29

ICPC

Skin symptom/complaint other

1.3

19.0

1435

11323

Z93

ICD-10 Finland

Artificial opening status

5.7

18.9

EB1VA, ,

NOMESCO Finland

1.3

18.9

1442

11390

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

6.2

18.9

M25.9

ICD-10 Finland

Joint disorder, unspecified

2.7

18.9

100

373

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

18.8

254

1386

L60

ICPC

Musculoskeletal, Result test/procedure

6.3

18.8

Z20.1

ICD-10 Finland

Contact with and exposure to tuberculosis

3.8

18.8

152

107

Kela drug reimbursment

Pernicious anaemia

2.7

18.7

352

WVA20, ,

SPAT

1.8

18.7

258

1418

D11

ICPC

Diarrhoea

1.4

18.7

1026

7714

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.6

18.7

108

421

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.3

18.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

18.6

709

5000

WX212

NOMESCO Finland

Femoral plexus blockade

2.4

18.6

132

566

R52.9

ICD-10 Finland

Pain, unspecified

1.4

18.6

754

5380

A28

ICPC

Limited function/disability NOS

1.4

18.5

729

5173

RF310, ,

NOMESCO Finland

4.7

18.4

UJF34

NOMESCO Finland

Left colonoscopy

3.7

18.4

159

TNC10

NOMESCO Finland

Joint puncture, elbow joint

30.1

18.3

L30.8

ICD-10 Finland

Other specified dermatitis

1.9

18.3

229

1220

EB1WA, ,

NOMESCO Finland

3.4

18.3

188

NCF15

NOMESCO Finland

Synovectomy of elbow joint, arthroscopic

16.2

18.3

NA6BG, ,

SPAT

4.3

18.3

111

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

18.3

276

1560

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

18.2

3479

30606

J20

ICD-10 Finland

Acute bronchitis

1.4

18.2

765

5495

D06BX01

ATC

metronidazole; topical

1.4

18.2

748

5352

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.0

18.1

255

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

18.1

1318

10340

S01XA18

ATC

ciclosporin; ophthalmic

3.1

18.0

230

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

18.0

593

4066

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

17.9

216

1136

R4110, ,

SPAT

1.4

17.9

856

6286

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

4.5

17.9

S76

ICPC

Skin infection other

1.7

17.9

353

2149

EB4VA, ,

NOMESCO Finland

1.3

17.9

1535

12311

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

17.9

588

4028

S70

ICPC

Herpes zoster

2.1

17.8

162

770

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

1.9

17.8

238

1295

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

2.4

17.8

123

522

D82

ICPC

Teeth/gum disease

1.2

17.7

3216

28123

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

17.7

369

2279

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

5.6

17.7

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

17.7

221

1177

D01BA02

ATC

terbinafine; oral

1.3

17.7

1676

13614

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

17.7

260

1458

RF212, ,

NOMESCO Finland

5.2

17.6

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

17.5

122

519

R74

ICPC

Upper respiratory infection acute

1.2

17.5

3102

27048

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

4.8

17.5

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

17.5

186

938

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.1

17.5

163

783

D01AE16

ATC

amorolfine; topical

1.5

17.5

651

4572

M66.2

ICD-10 Finland

Spontaneous rupture of extensor tendons

5.9

17.4

71599

ICD-8 Finland

Arthritis, unspecified

5.5

17.4

B01AF01

ATC

rivaroxaban; oral

1.5

17.3

611

4245

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022948) Iron [Moles/volume] in Serum or Plasma

2503

11776

2.57

314.86

2.7

2.6

13.01

14.17

umol/l

11.14

2416

11091

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1665

671

30.38

307.65

1.1

1.61

1.98

iu/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

850

1709

5.40

307.65

2.4

6.9

467.37

860.42

iu/ml

0.91

249

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1221

169

83.74

307.65

3.6

4.2

9.45

7.25

mg/l

4.95

1003

129

(3018010) Neutrophils/Leukocytes in Blood

8081

36544

16.04

307.65

21.2

6.1

54.77

56.35

35.84

8071

35130

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3215

14326

2.96

307.65

1.5

1.3

45.04

8.00

u/ml

29.49

1445

5952

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3179

15641

2.62

307.65

1.5

1.3

79.44

24.12

iu/ml

14.23

1287

4605

(3015736) pH of Urine

6022

32425

3.72

307.65

5.2

3.1

6.20

6.19

0.15

3135

18810

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5078

30944

2.52

307.65

6.1

3.3

0.30

0.06

estimate

0.38

1696

6697

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1214

3284

4.13

307.65

1.3

0.28

1.17

u/ml

3.59

241

(3003329) Lymphocytes/Leukocytes in Synovial fluid

615

499

13.18

307.65

2.2

1.5

41.77

31.68

4.97

434

293

(3028026) IgM [Mass/volume] in Serum or Plasma

1685

4951

3.97

307.65

1.7

1.9

1.23

1.26

g/l

0.34

1611

4615

(3017143) Hepatitis C virus Ab [Presence] in Serum

4300

11717

6.23

307.65

1.4

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

7143

39968

5.20

307.65

6.1

3.4

0.00

estimate

2.57

1941

8089

(3002030) Lymphocytes/Leukocytes in Blood

8100

37190

16.03

307.65

21.9

6.2

31.26

29.15

74.85

8079

35477

(3006571) Granulocytes/Leukocytes in Synovial fluid

785

657

13.02

307.65

2.2

1.5

48.71

56.24

3.44

563

400

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4757

17056

4.90

307.65

1.5

1.8

—

(3013115) Eosinophils [#/volume] in Blood

8661

40641

78.67

307.65

22.4

6.4

0.19

e9/l

0.73

8488

35906

(3013650) Neutrophils [#/volume] in Blood by Automated count

8668

43699

72.44

307.65

24.1

9.6

3.83

3.99

e9/l

15.10

8474

38009

(3006315) Basophils [#/volume] in Blood

8659

39318

82.28

307.65

22.0

6.2

0.04

e9/l

26.31

8448

34138

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3239

7808

5.99

307.65

1.3

1.6

—

(3025159) Blasts/Leukocytes in Blood

2847

6119

6.40

307.65

9.4

4.7

0.01

0.31

2.22

781

1404

(3021440) Promyelocytes/Leukocytes in Blood

2828

5978

6.50

307.65

8.9

4.5

0.04

0.12

9.00

763

1488

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8648

55899

35.10

307.65

20.7

7.7

71.66

76.64

u/l

40.53

8631

53395

(3010144) Erythrocytes [#/volume] in Synovial fluid

511

507

10.64

307.65

2.0

1.3

16082.39

107341.44

e6/l

2.74

351

344

(3014051) Protein [Presence] in Urine by Test strip

4012

23027

2.37

307.65

4.1

2.6

0.15

0.04

0.65

346

(3022096) Basophils/Leukocytes in Blood

8016

35799

15.09

307.65

22.2

6.4

0.78

0.69

58.05

7996

33727

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1063

164

73.60

307.65

2.8

2.9

139.62

162.22

au/ml

0.22

168

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1478

1524

11.46

307.65

2.0

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2129

3290

8.22

307.65

1.7

2.0

8.77

6.87

iu/ml

0.29

443

815

(3000475) Leukocytes [#/volume] in Synovial fluid

1359

1408

11.23

307.65

2.4

1.5

9040.25

13455.15

e6/l

1.84

1063

989

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1416

3377

4.81

307.65

1.3

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

3661

11870

4.57

307.65

8.9

2.3

235.97

110.41

ug/g

67.25

3388

9459

(3018095) Leukocytes [#/volume] in Urine

4717

26861

2.63

307.65

5.2

3.7

49.98

70.54

e6/l

1.21

3278

18296

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

4458

2142

41.21

307.65

1.6

1.5

4.26

0.22

iu/ml

0.53

855

369

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1098

2586

4.71

307.65

1.2

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

7158

40347

5.17

307.65

6.2

3.5

2.22

4.55

estimate

0.85

1953

8137

(3005719) IgG [Mass/volume] in Serum or Plasma

2177

6336

4.24

307.65

2.9

10.77

10.46

g/l

3.07

2081

5893

(3045414) Leukocytes [Presence] in Urine

1869

6641

3.30

307.65

2.3

2.0

0.01

0.03

estimate

3.10

595

1514

(3037522) Nuclear Ab [Titer] in Serum

4271

11838

6.07

307.65

1.6

1.4

446.05

523.95

titre

2.31

1144

2291

(40758558) Short blood count panel - Blood

4369

22587

2.86

307.65

12.5

6.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

348

275

13.14

307.65

2.0

1.5

4.43

4.29

0.04

102

(46235355) HIV 1 and 2 tests - Meaningful Use set

4433

21185

3.20

307.65

1.7

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5360

30691

2.91

307.65

9.0

5.1

36.51

36.77

g/l

3.36

5212

29004

(3019069) Monocytes/Leukocytes in Blood

8081

35902

16.53

307.65

22.1

6.4

8.95

8.57

38.98

8060

33927

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3743

18037

2.87

307.65

3.8

2.3

2.75

2.65

mg/l

2.34

3509

15771

(3006504) Eosinophils/Leukocytes in Blood

8056

35831

15.97

307.65

21.9

6.3

2.81

2.84

0.61

8033

33808

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1367

3077.25

307.65

1.7

1.0

128.13

—

au/ml

—

198

(3001604) Monocytes [#/volume] in Blood

8658

39250

81.90

307.65

21.9

6.1

0.59

0.56

e9/l

51.67

8447

34109

(3017181) Myelocytes/Leukocytes in Blood

2943

6223

6.61

307.65

8.6

4.5

0.47

0.96

19.68

883

1732

(3002179) Metamyelocytes/Leukocytes in Blood

2891

5931

6.77

307.65

7.9

4.3

0.26

0.70

29.15

845

1646

(3008898) HLA-B27 [Presence]

1352

3551

4.32

307.65

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

7166

40574

5.15

307.65

6.3

3.5

0.01

0.19

estimate

0.73

1885

7762

(3035933) Granulocytes/Leukocytes in Blood

1169

1649

8.02

307.65

4.7

3.1

55.67

57.48

4.24

1169

1649

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6450

34389

4.29

307.65

4.0

2.5

75.47

74.58

nmol/l

1.98

6310

32098

(3022145) Colonoscopy Study observation

2627

8434

4.02

307.65

2.2

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

8657

40336

77.32

307.65

22.2

6.2

2.07

1.97

e9/l

14.93

8485

35897

(3017732) Neutrophils [#/volume] in Blood

3545

9639

5.49

307.65

3.8

3.1

3.90

4.40

e9/l

5.00

3338

8572

(3011397) Hemoglobin [Presence] in Urine by Test strip

3561

17845

2.67

307.65

6.3

3.4

0.69

0.17

0.85

135

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1827

4569

4.79

307.65

2.3

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

4108

21206

2.76

307.65

6.8

3.6

0.00

estimate

3.90

1892

7615

(3021589) Normoblasts [#/volume] in Blood

6531

34505

4.47

307.65

25.0

10.2

0.00

e9/l

2.41

6150

28052

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8576

55688

23.28

307.65

15.5

3.9

11.77

9.85

mm/h

40.02

8518

52781

(3045424) Erythrocytes [Presence] in Urine

1267

3364

4.23

307.65

2.3

2.0

0.01

0.23

estimate

0.55

558

1196

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

242

42.88

307.65

3.2

2.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2211

9969

2.63

302.07

2.6

2.7

21.80

23.84

9.64

2122

9352

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2337

10907

2.56

296.50

2.6

2.40

g/l

0.08

2240

10169

(3000850) Epithelial cells [#/volume] in Urine

2919

15227

2.37

288.65

3.2

2.6

4.78

6.29

e6/l

9.19

2734

13848

(3041096) Erythrocytes [Presence] in Urine by Automated

3862

23012

2.21

274.08

4.7

2.9

0.02

0.09

estimate

0.99

1687

6528

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8758

76724

41.12

259.87

35.3

13.0

13.98

21.93

mg/l

218.66

8368

61574

(3002582) Erythrocytes [#/volume] in Urine

3773

22651

2.17

258.58

4.0

3.2

25.47

73.41

e6/l

5.99

3133

16889

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5003

33736

2.12

249.78

6.7

7.4

1.22

1.21

mmol/l

2.41

4420

29460

(3030467) Casts [#/volume] in Urine by Automated count

3361

19558

2.16

246.65

3.6

3.1

0.29

0.35

e6/l

1.00

2688

13898

(3018418) pH of Serum or Plasma

3427

20171

2.15

243.42

3.6

4.4

7.40

0.11

2473

14184

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

232

+∞

242.82

1.3

0.0

1.67

—

mg/l

—

198

(3042936) Bacteria identified in Isolate by Culture

2098

10110

2.41

241.92

2.4

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3184

18326

2.16

238.55

1.7

1.5

2.66

2.25

g/l

27.38

2338

11939

(3007566) Smooth muscle Ab [Titer] in Serum

836

2476

3.63

236.22

1.4

1.3

80.90

112.90

titre

0.75

255

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8448

72726

5.17

231.84

25.7

12.1

93.04

89.12

ml/min/173m2

67.91

8176

66332

(3034770) Mitochondria Ab [Titer] in Serum

817

2429

3.61

229.32

1.4

1.3

868.33

1083.48

titre

0.20

(3009871) Measles virus Ab [Titer] in Serum

293

346

8.73

229.05

1.6

1.7

3611.58

3543.11

titre

0.04

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5338

37686

2.06

225.44

6.1

6.5

9.90

10.81

umol/l

9.54

5166

35910

(3009445) Proteinase 3 Ab [Units/volume] in Serum

927

3031

3.30

223.88

1.5

1.7

8.52

13.84

iu/ml

0.79

(36304419) Bacteria [Presence] in Urine

3216

18964

2.10

222.66

3.4

3.0

1280.63

53.12

estimate

—

(3023368) Bacteria identified in Blood by Culture

2993

17223

2.12

220.70

4.7

4.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

476

979

5.08

217.58

2.9

3.5

0.93

1.62

3.77

442

892

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4477

30124

1.99

211.08

6.2

6.8

1.22

1.21

mmol/l

2.19

4302

28196

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1295

5356

2.66

203.48

2.3

2.4

0.19

0.38

e6/l

5.65

1182

5073

(3014148) Varicella zoster virus Ab [Titer] in Serum

579

1496

4.07

198.26

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

3022

18031

2.03

197.30

6.8

3.5

1.47

1.28

kg/l

0.16

2219

11583

(3024263) Appearance of Synovial fluid

247

285

8.89

196.54

3.6

1.5

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

7898

66848

2.79

189.88

37.3

16.0

13.73

13.38

116.12

7889

66012

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

699

2128

3.48

188.19

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

763

2559

3.17

175.24

1.6

1.9

0.23

g/l

1.78

726

2445

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

776

2646

3.12

173.22

1.4

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5391

40110

1.89

173.10

4.3

3.2

107.22

102.95

ug/l

0.48

5239

38151

(3032080) INR in Blood by Coagulation assay

4222

29190

1.86

170.02

9.2

10.5

1.10

1.15

inr

13.51

3565

24103

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

771

2649

3.09

169.77

1.6

1.8

1.21

1.20

g/l

0.72

731

2541

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4009

27427

1.85

165.53

4.2

3.3

33.15

33.02

u/l

0.03

3821

26051

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2161

12264

2.01

155.89

3.0

2.8

0.83

1.03

e6/l

2.37

1337

6196

(3025941) Bacteria identified in Stool by Culture

1080

4700

2.48

149.93

1.4

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

617

2012

3.22

147.92

1.3

9.79

16.29

u/ml

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2950

18911

1.84

145.28

2.5

314.99

330.66

umol/l

17.17

2747

17208

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8764

81268

28.56

143.70

35.9

10.5

28.29

27.57

u/l

3.94

8759

79525

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

618

2068

3.14

141.73

1.2

1.3

274.93

247.28

u/ml

1.49

368

1298

(3017354) Segmented neutrophils/Leukocytes in Blood

300

609

5.06

138.73

2.9

3.3

51.93

57.49

4.45

260

534

(3013166) Neutrophils/Leukocytes in Synovial fluid

154

151

10.36

138.20

1.9

1.3

43.06

51.99

1.57

141

130

(3027945) Reticulocytes/Erythrocytes in Blood

1357

6737

2.20

137.98

3.4

3.0

1.81

1.76

1.03

1267

6083

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

670

2405

2.93

135.70

1.3

5.46

10.03

u/ml

1.46

337

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

634

2212

3.01

135.10

1.2

1.3

25.00

47.40

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

667

2405

2.92

133.95

1.3

7.43

5.25

u/ml

0.18

209

(40761536) Microorganisms panel - Urine sediment

1250

6086

2.23

133.04

4.6

3.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1508

7926

2.09

131.83

2.1

2.3

323.94

375.67

nmol/l

21.97

1452

7380

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

588

1993

3.09

131.72

1.5

5.14

14.46

iu/ml

1.79

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

698

2603

2.83

131.64

1.3

20.37

36.31

u/ml

0.95

140

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

578

1954

3.10

130.03

1.3

6.28

4.30

u/ml

0.23

120

(3007853) Bacteria identified in Skin by Aerobe culture

1630

8867

2.03

129.51

1.9

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

872

3680

2.52

128.37

1.3

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

146

148

10.01

127.94

1.7

1.2

42.49

36.19

0.91

116

(3000494) Fungus identified in Specimen by Culture

1699

9424

2.00

127.58

1.6

1.5

—

(3026782) Osmolality of Urine

2121

12922

1.85

118.74

3.3

2.8

528.41

535.65

mosm/kgh2o

0.77

1939

11344

(3031040) Bacteria [#/volume] in Urine by Automated count

5909

47828

1.72

116.74

5.3

4.1

1116.78

1160.03

e6/l

0.03

559

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3343

23302

1.70

116.74

3.8

2.7

62.66

62.36

u/l

0.02

3176

21758

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

318

820

3.99

108.49

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

253

560

4.62

105.39

1.1

1469.37

1489.13

miu/ml

0.10

253

560

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

100

+∞

104.36

1.2

0.0

28.59

—

mg/l

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

457

1529

3.10

104.30

1.6

0.66

0.76

g/l

0.86

347

1201

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

525

1913

2.86

102.85

1.9

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1260

6748

2.01

102.49

3.3

2.5

0.23

0.22

g/l

5.35

1213

6354

(3023520) Reticulocytes [#/volume] in Blood

1012

4997

2.16

102.34

2.3

2.9

73.56

71.49

e9/l

0.93

751

3578

(40768797) Stomach Pathology biopsy report

1705

10147

1.84

100.77

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1732

10372

1.83

100.27

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

104

11.30

99.33

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

285

728

4.01

98.47

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

508

1869

2.82

97.66

2.5

2.8

3.07

2.29

index

0.41

248

990

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

287

742

3.96

97.51

1.3

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

13.82

96.27

1.1

31.82

24.67

u/ml

0.37

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

13.82

96.27

1.1

43.23

27.93

u/ml

0.58

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

274

696

4.03

95.39

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

279

719

3.97

95.21

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

279

720

3.97

95.03

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2993

21123

1.63

94.35

1.4

1.27

1.74

u/ml

1.63

902

6099

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

368

1148

3.30

94.30

1.4

1.5

11.95

12.08

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

402

1326

3.13

93.90

1.8

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

314

889

3.63

93.58

1.5

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

364

1136

3.30

93.21

1.2

4.67

17.17

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

965

4843

2.11

93.12

2.0

2.7

67.64

66.95

g/l

1.96

916

4538

(3021960) Folate [Moles/volume] in Serum or Plasma

2642

18150

1.65

92.29

1.8

1.6

20.44

19.97

nmol/l

0.72

2414

15809

(40768443) Skin Pathology biopsy report

726

3268

2.33

91.53

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

502

1906

2.73

90.77

2.7

2.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

243

593

4.19

89.29

2.7

4.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

266

694

3.92

89.21

1.3

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

165

291

5.76

89.05

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

261

675

3.95

88.62

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

475

1782

2.76

87.86

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

202

442

4.65

85.33

1.3

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3873

29659

1.55

82.87

2.2

1.9

93.24

98.01

pmol/l

9.17

2474

15981

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

506

2042

2.57

80.82

1.3

52.02

43.81

u/ml

0.43

183

(3013826) Glucose [Moles/volume] in Serum or Plasma

5151

42135

1.54

80.29

5.1

5.0

6.36

6.52

mmol/l

7.71

4928

39455

(3019550) Sodium [Moles/volume] in Serum or Plasma

8196

75596

2.25

79.98

18.7

14.6

139.37

139.71

mmol/l

38.49

8086

74144

(3023103) Potassium [Moles/volume] in Serum or Plasma

8211

75822

2.26

79.35

18.9

14.7

3.91

3.94

mmol/l

31.54

8085

74197

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2049

13661

1.65

78.22

2.0

1.7

27554767.30

31601684.62

pmol/l

0.09

1840

11797

(3036670) Protein [Mass/volume] in Synovial fluid

109

145

7.60

77.03

1.3

1.2

41.17

39.43

g/l

0.49

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1241

7244

1.83

76.08

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

520

2194

2.46

75.48

2.0

1.54

2.00

ug/l

0.57

462

1998

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1280

7579

1.81

74.76

1.7

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

412

1563

2.72

74.43

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1244

7360

1.80

72.70

2.8

4.9

224.58

238.05

u/l

4.23

1193

7030

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

243

694

3.57

71.43

1.4

1.2

282.50

141.67

titre

0.43

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

243

694

3.57

71.43

1.4

1.2

222.22

176.96

titre

0.44

112

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

522

2289

2.36

69.44

1.6

2.3

7.59

7.22

g/l

5.02

502

2146

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

521

2285

2.36

69.28

1.6

2.3

4.05

3.68

g/l

7.07

501

2145

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

521

2286

2.36

69.21

1.6

2.3

4.41

4.25

g/l

3.26

501

2144

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

376

1415

2.73

68.96

1.8

3.5

530.59

1062.59

u/ml

0.64

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

499

2182

2.36

66.77

1.5

2.3

3.10

2.85

g/l

5.76

478

2040

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

691

3451

2.09

66.66

1.6

2.1

37.68

40.04

u/l

2.58

649

3166

(3039162) Centromere protein B Ab [Units/volume] in Serum

312

1084

2.95

66.41

1.3

43.59

63.86

u/ml

0.43

(3041672) Baker's yeast Ab [Presence] in Serum

11.84

66.05

1.1

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

65.70

1.2

0.0

341.00

—

au/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

243

733

3.38

65.64

1.2

51.23

62.48

u/l

2.93

219

647

(3019309) Folate [Moles/volume] in Red Blood Cells

1462

9317

1.68

64.96

1.9

1.7

1186.86

1163.80

nmol/l

0.42

1177

7293

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

340

1254

2.78

64.79

1.3

106.67

183.75

titre

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

570

2681

2.20

64.10

1.6

1.8

1.58

1.47

g/l

1.70

487

2327

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

335

1242

2.76

63.21

1.3

460.54

348.60

titre

0.40

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1693

11301

1.62

62.38

3.2

2.9

3.06

3.04

e6/l

0.02

873

5202

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

415

1741

2.45

60.83

1.6

2.2

0.01

g/l

0.55

383

1592

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

243

774

3.20

60.10

1.2

24.86

41.82

u/ml

—

(4062490) Immunoglobulin typing, IgG

272

926

3.00

60.02

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

275

943

2.98

59.91

1.3

1.4

0.41

0.39

g/l

0.41

189

673

(3027135) IgG subclass 1 [Mass/volume] in Serum

275

943

2.98

59.91

1.3

1.4

6.74

6.51

g/l

0.50

188

675

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4327

35324

1.44

59.85

3.0

2.7

—

estimate

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

399

1656

2.48

59.85

1.5

2.2

0.00

g/l

-0.00

352

1475

(3028192) IgG subclass 2 [Mass/volume] in Serum

275

944

2.97

59.80

1.3

1.4

3.09

2.93

g/l

0.65

188

678

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1026

6066

1.78

59.28

2.4

19.70

19.38

au/ml

0.05

114

793

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

445

1953

2.35

58.95

1.5

2.3

10.73

10.10

g/l

2.36

423

1797

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

182

488

3.79

58.74

1.4

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

277

4.82

58.70

1.5

2.0

9255.82

17134.94

u/ml

0.24

(3004616) Nuclear Ab [Presence] in Serum

280

989

2.89

57.83

1.3

—

(3001729) Color of Synovial fluid

15.23

57.07

2.6

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

446

1988

2.31

56.98

1.7

2.3

0.24

0.82

g/l

6.52

404

1760

(3007461) Platelets [#/volume] in Blood

8770

85026

15.55

56.59

48.5

20.0

276.18

257.89

e9/l

124.76

8754

83650

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

411

1780

2.37

56.09

1.4

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

892

5140

1.82

56.00

3.0

4.0

1.23

mmol/l

1.00

820

4490

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

393

1670

2.42

55.97

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

109

203

5.42

55.55

1.4

1.6

9.71

9.04

ug/l

0.68

109

203

(3026361) Erythrocytes [#/volume] in Blood

8770

85071

15.30

55.55

48.3

19.9

4.49

4.58

e12/l

69.36

8747

83529

(3010813) Leukocytes [#/volume] in Blood

8770

85084

15.22

55.26

48.4

20.0

6.98

6.62

e9/l

56.94

8748

83511

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

339

1356

2.56

54.95

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

416

1857

2.30

52.93

1.5

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

252

882

2.91

52.93

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

253

888

2.90

52.86

1.7

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

948

5657

1.76

52.71

1.3

41.31

49.88

au/ml

0.65

359

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

254

902

2.87

51.95

1.7

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

364

1547

2.41

51.80

1.5

2.3

0.00

g/l

-0.00

351

1473

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

461

2167

2.19

51.75

1.7

2.2

10.40

11.12

mg/l

1.23

438

2061

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2736

20988

1.44

50.44

2.1

2.2

139.91

205.32

u/l

7.94

2627

20043

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

394

1755

2.30

50.37

2.0

3.6

34.48

46.20

mg/l

0.96

322

1485

(3033658) Prothrombin time (PT) actual/Normal

2521

19067

1.45

50.06

4.8

4.1

95.08

93.70

2.38

2460

18646

(3034860) Kappa light chains.free [Mass/volume] in Serum

393

1754

2.30

50.01

2.0

3.6

45.67

48.72

mg/l

0.22

320

1483

(3037756) Immunofixation for Serum or Plasma

272

1038

2.67

48.50

1.4

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

194

615

3.20

48.40

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

182

555

3.33

48.37

1.2

62.17

45.11

u/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

192

606

3.22

48.25

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

234

838

2.84

47.14

1.7

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

424

2003

2.17

46.96

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

234

844

2.82

46.51

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

234

846

2.81

46.31

1.7

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

128

318

4.07

46.01

1.0

1.1

3.75

3.92

iu/ml

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

14.71

45.90

3.0

1.3

0.11

0.37

0.68

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

150

419

3.62

45.66

1.2

18.55

23.69

u/l

0.63

131

350

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

151

430

3.56

44.66

1.2

72.40

91.71

u/l

1.86

132

365

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

261

1036

2.57

42.99

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

348

1575

2.26

42.81

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1016

6514

1.63

42.69

3.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2999

23921

1.39

42.34

2.6

3.5

2.34

2.35

mmol/l

9.54

2827

22088

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

141

406

3.51

41.04

1.6

5.13

5.91

u/l

0.33

112

327

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

405

2007

2.07

39.55

1.3

1.5

42.37

25.44

u/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

205

753

2.76

39.41

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2273

17472

1.41

39.35

1.9

1.09

1.03

mg/l

0.62

1740

13199

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

312

1399

2.28

39.24

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

218

831

2.66

38.99

1.8

2.7

1251.05

1245.67

e6/l

0.02

190

706

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

337

1570

2.19

38.62

1.9

3.4

3.37

2.91

ratio

0.15

174

863

(42529406) Shigella sp [Presence] in Stool by Culture

420

2134

2.02

38.29

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

752

4584

1.70

38.21

1.2

1.1

149.29

213.11

titre

—

156

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

381

1871

2.08

38.12

1.3

1.5

142.06

146.10

au/ml

0.22

555

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3075

24961

1.36

37.70

3.4

3.2

205.49

50.88

ng/l

0.43

1816

14298

(3000330) Specific gravity of Urine by Test strip

551

3082

1.84

37.66

3.4

2.9

1.02

ratio

0.05

511

2737

(3014765) Yersinia sp identified in Stool by Organism specific culture

416

2123

2.01

37.46

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

270

1162

2.37

37.36

1.5

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

184

658

2.83

37.22

1.8

2.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

135

403

3.39

37.19

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1288

8979

1.51

37.12

3.0

2.9

6.17

7.36

umol/l

1.66

1133

7809

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

413

2112

2.00

36.97

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

277

1214

2.32

36.77

1.1

1.47

1.49

g/l

0.32

262

1117

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

277

1242

2.27

34.86

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

217

889

2.48

33.50

1.4

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

932

6201

1.56

33.05

1.4

1.3

130.92

237.85

u/ml

4.64

882

5790

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

212

865

2.49

33.02

1.4

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

175

652

2.72

32.79

1.0

1.1

—

0.54

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

355

3.36

32.16

1.2

—

(40768441) Liver Pathology biopsy report

163

595

2.77

31.78

1.3

1.5

—

(1175426) CD3 cells/Lymphocytes in Blood

180

692

2.63

31.72

1.8

2.4

73.81

73.44

0.14

171

669

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2053

15998

1.37

31.48

2.8

3.0

896.53

899.37

ng/l

0.01

1742

13298

(3010503) CD19 cells [#/volume] in Blood

136

457

3.01

30.85

1.8

2.8

136.62

279.80

e6/l

0.83

131

443

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1062

7410

1.49

30.01

3.0

2.6

40.86

46.72

u/l

0.37

928

6325

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

688

4369

1.62

29.60

1.1

22.04

18.57

u/ml

0.06

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

101

295

3.45

28.87

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1251

9091

1.44

28.55

5.1

6.9

1.03

1.05

mmol/l

1.23

1197

8542

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

169

666

2.57

28.36

1.8

2.4

15.07

14.14

0.51

164

654

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

137

490

2.82

27.80

1.4

1.5

5.69

6.30

u/l

0.47

121

427

(3022621) pH of Urine by Test strip

872

5936

1.52

27.63

3.2

2.3

6.00

6.11

3.78

628

3697

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

850

5769

1.52

27.30

3.1

2.6

74.68

74.06

ml/min/173m2

0.16

361

2308

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

180

755

2.41

26.48

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

203

3.82

25.65

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

203

3.82

25.65

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

203

3.82

25.65

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

203

3.82

25.65

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

121

430

2.84

24.90

1.1

—

(3042631) Mycobacterium sp identified in Specimen

171

723

2.39

24.74

2.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

113

391

2.91

24.42

1.2

1.1

71.97

78.68

u/l

0.46

108

353

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

280

3.27

24.03

1.1

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

209

977

2.17

23.85

1.4

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

879

12240

0.69

23.83

1.7

1.9

3.54

3.53

ratio

0.02

674

9183

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

233

1137

2.08

23.78

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

929

6594

1.46

23.77

4.1

4.5

5.77

5.84

kpa

1.49

905

6427

(3026389) Candida sp identified in Specimen by Organism specific culture

242

1198

2.05

23.76

1.4

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

208

977

2.16

23.45

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

208

977

2.16

23.45

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

208

977

2.16

23.45

1.4

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

221

3.55

23.43

1.2

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

127

479

2.68

23.36

1.4

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

304

3.11

22.88

1.7

2.2

25.43

30.54

3.33

304

(3012544) pH of Venous blood

934

6696

1.44

22.61

4.1

4.5

7.38

2.12

526

3740

(3023419) Bacteria identified in Sputum by Culture

178

798

2.26

22.53

2.2

3.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

151

634

2.41

22.23

1.8

3.0

207.11

217.79

e6/l

0.29

128

516

(3044889) 12 lead EKG panel

5579

51021

1.26

22.09

3.6

3.5

0.44

5723.11

—

(3002032) Base excess in Venous blood by calculation

894

6433

1.43

21.15

4.1

4.6

1.78

1.74

mmol/l

0.13

792

5658

(3044640) Blood type and Crossmatch panel - Blood

2815

23920

1.26

21.12

2.6

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

408

2.72

20.95

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

136

565

2.43

20.53

1.8

1.5

18.06

23.82

umol/l

1.84

130

522

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

167

759

2.22

20.49

1.1

279.66

287.00

mg/l

0.59

158

702

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

145

621

2.36

20.46

1.8

2.8

517.31

519.12

e6/l

0.01

111

485

(3014111) Lactate [Moles/volume] in Serum or Plasma

840

6032

1.43

20.06

8.6

8.8

1.27

1.30

mmol/l

0.57

827

5928

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1602

12748

1.31

20.03

2.1

2.8

2.44

2.43

mmol/l

1.74

1436

11447

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

648

9269

0.68

19.98

1.5

1.6

3.42

3.51

mmol/l

1.11

437

6198

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

160

3.77

19.75

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

360

2.74

19.05

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

367

2.72

18.91

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1478

11728

1.31

18.73

3.4

3.9

0.81

0.82

mmol/l

2.52

1403

11170

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

167

788

2.14

18.70

1.4

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1577

12644

1.30

18.49

3.6

3.5

352.84

441.16

ng/l

0.63

1037

8393

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

130

557

2.35

18.37

1.2

1.06

ratio

0.32

108

459

(36660697) Celiac disease serology panel - Serum

979

7329

1.38

18.29

1.2

—

(3000012) Reticulocyte production index

160

751

2.15

18.17

1.8

2.2

1.03

0.91

1.58

112

480

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

240

3.10

18.02

3.6

4.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

110

441

2.51

17.98

1.1

9.73

13.61

u/ml

0.17

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

536

3608

1.52

17.75

1.6

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

370

2.64

17.56

1.5

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

389

2.59

17.41

1.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

656

4632

1.45

17.09

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

248

3.00

17.05

2.3

3.8

0.80

1.40

2.46

248

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

127

557

2.30

17.04

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

127

557

2.30

17.04

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

127

557

2.30

17.04

1.4

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

266

2.91

16.82

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

266

2.91

16.82

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

5.55

16.46

1.4

1.3

5.17

5.52

mmol/l

0.17

(3028433) Virus identified in Specimen by Culture

234

3.01

16.22

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

125

558

2.26

16.12

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

230

1287

1.81

15.78

1.5

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

751

5530

1.39

15.43

3.6

4.0

4.68

4.73

kpa

0.30

734

5378

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

126

3.74

15.42

1.6

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2146

18192

1.24

15.41

2.5

2.3

—

(3016502) Oxygen saturation in Arterial blood

844

6345

1.37

15.26

9.4

9.3

96.07

96.00

0.12

823

6134

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

127

3.72

15.25

1.3

1.8

206904.04

353277.86

nmol/l

0.21

107

(3027801) Oxygen [Partial pressure] in Arterial blood

938

7180

1.34

15.07

9.1

8.8

12.85

13.06

kpa

0.58

918

6935

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

938

7182

1.34

15.04

9.1

8.8

5.01

5.10

kpa

2.56

917

6937

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

363

2335

1.58

14.77

1.7

2.5

264.97

568.15

ug/l

1.78

325

2203

(3019977) pH of Arterial blood

936

7185

1.34

14.74

9.2

8.8

7.42

2.46

478

3825

(3021901) Oxygen saturation in Capillary blood

227

1299

1.77

14.48

3.1

3.0

91.58

91.17

0.63

222

1268

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

374

2.45

14.20

1.6

1.4

25.50

21.20

u/ml

0.28

(37208534) Antinuclear antibody arbitrary concentration in serum

292

2.65

14.19

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

342

2193

1.58

14.12

1.5

1.4

292.58

283.29

ug/g

0.34

186

1220

(3003396) Base excess in Arterial blood by calculation

924

7123

1.33

14.12

9.1

8.7

0.79

0.80

mmol/l

0.03

780

5858

(1616796) Gas panel - Central venous blood

249

1477

1.71

14.00

2.9

3.8

—

(4034850) Laboratory test

343

2209

1.58

13.90

12.1

8.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

141

701

2.03

13.87

1.5

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

605

4378

1.41

13.75

3.4

3.7

5.07

5.15

kpa

1.81

587

4219

(3002173) Hemoglobin [Mass/volume] in Arterial blood

799

6054

1.35

13.70

10.1

9.7

120.81

123.29

g/l

2.85

788

5911

(3028626) Oxygen [Partial pressure] in Capillary blood

294

1832

1.63

13.68

3.3

4.0

8.72

8.78

kpa

0.26

288

1790

(21494890) Protein electrophoresis panel - 24 hour Urine

113

519

2.19

13.67

1.5

2.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.97

13.57

1.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

107

485

2.22

13.38

2.0

2.8

45.66

43.14

0.77

247

(3051611) Lipemic interference index of Serum or Plasma

126

614

2.07

13.11

2.9

3.3

18.08

13.49

index

1.66

402

(3020891) Body temperature

424

2902

1.48

12.98

4.4

4.6

36.92

36.93

°c

0.10

419

2883

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

217

1268

1.73

12.91

1.2

2.49

0.79

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.97

12.86

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

4.34

12.84

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3621

32692

1.18

12.79

2.0

1.9

1.46

1.40

mmol/l

3.15

3207

28375

(3009343) pH of Capillary blood

585

4263

1.40

12.77

3.4

3.7

7.42

7.41

1.71

500

3533

(4024509) Urine culture

443

3078

1.46

12.57

2.0

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6494

61676

1.20

12.44

4.4

4.5

14.75

14.52

pmol/l

12.64

6119

57835

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

365

2446

1.51

12.39

2.2

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

244

1491

1.65

12.31

1.3

1.2

2.36

3.42

u/ml

0.91

107

545

(3000991) Gas panel - Venous blood

779

5983

1.33

12.17

10.3

10.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

149

792

1.90

12.14

1.4

1.5

—

(3013512) EKG study

2483

21770

1.20

12.11

3.2

3.1

0.80

0.76

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

573

4202

1.39

12.05

4.3

4.9

24.28

24.25

mmol/l

0.12

567

4164

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

483

3444

1.43

11.94

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7420

71530

1.24

11.60

5.1

5.3

1.71

1.81

mu/l

11.29

7069

67837

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

228

3630

0.62

11.55

1.5

1.7

7.12

4.16

mg/l

1.79

183

2635

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

662

5025

1.34

11.19

3.5

4.3

75.71

84.42

ng/l

0.92

615

4472

(21494755) Public health laboratory ask at order entry panel

878

10996

0.78

11.13

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

504

3669

1.40

11.08

6.7

7.2

24.53

24.43

mmol/l

0.28

489

3504

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

333

2247

1.50

10.98

2.0

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

764

5937

1.31

10.97

6.3

9.0

8.27

8.40

mmol/l

0.21

733

5741

(3001964) Herpes simplex virus Ag [Presence] in Specimen

207

2.72

10.94

1.2

1.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

396

2.21

10.85

1.8

2.6

28.18

28.91

0.18

384

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

218

1349

1.63

10.53

1.1

3.57

2.79

0.56

280

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

507

3731

1.38

10.46

3.2

3.7

1.63

1.53

mmol/l

0.27

366

2748

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

111

564

1.98

10.39

3.9

4.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

336

2.27

10.19

1.3

88.00

52.50

titre

—

(3010375) cycloSPORINE [Mass/volume] in Blood

395

2.16

10.11

13.0

28.9

145.49

118.40

ug/l

0.73

315

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

171

2.82

10.07

1.2

1.1

—

(3017704) Immunofixation for Urine

288

2.37

10.07

1.6

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

159

919

1.74

9.94

8.0

6.9

11.89

10.95

mg/l

1.60

148

863

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1234

10292

1.23

9.84

2.2

2.4

29.35

29.41

0.13

1196

10036

(3028679) Herpes simplex virus Ab [Presence] in Serum

115

604

1.92

9.80

1.2

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

457

3355

1.38

9.58

3.3

3.5

0.65

0.62

1.12

457

3340

(3000093) Morphology [Interpretation] in Blood Narrative

115

609

1.90

9.57

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

102

3.34

9.55

2.1

2.0

—

(3044927) Protein electrophoresis panel - Urine

500

1.99

9.47

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

374

2659

1.42

9.46

5.4

5.3

1.59

1.69

0.90

361

2496

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

148

853

1.75

9.37

1.1

—

(3012501) Base excess in Blood by calculation

215

1375

1.58

9.12

2.9

3.9

2.17

2.31

mmol/l

0.37

144

898

(3006184) Hemoglobin [Mass/volume] in Capillary blood

240

1574

1.54

9.11

2.7

2.2

132.13

132.86

g/l

0.20

183

1238

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

334

2.20

9.07

1.5

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.42

9.02

1.1

1.2

1.34

1.82

iu/ml

0.81

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

526

3990

1.34

8.96

1.3

222.89

223.67

miu/ml

0.01

197

1900

(3005011) Chlamydia sp Ab [Titer] in Serum

122

3.04

8.94

1.4

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

488

3662

1.35

8.93

10.2

11.3

15.99

16.24

1.21

478

3526

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

538

4101

1.33

8.87

2.6

2.8

114.30

136.41

ng/l

1.15

480

3676

(3045716) Anion gap in Serum or Plasma by calculation

120

663

1.82

8.79

3.6

3.3

9.95

10.67

mmol/l

1.64

120

652

(3006245) CD3-CD19+ cells/cells in Blood

425

2.03

8.77

1.9

2.8

10.23

9.68

0.23

409

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

199

1262

1.59

8.77

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

199

1262

1.59

8.77

1.3

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

334

2.17

8.66

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

334

2.17

8.66

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

334

2.17

8.66

1.5

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.38

8.60

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

497

1.94

8.60

1.3

1.2

11.76

8.91

mm/h

1.19

497

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

357

2564

1.41

8.56

3.3

5.0

1.34

1.35

mg/l

0.08

337

2410

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

108

586

1.85

8.40

1.8

2.9

0.83

0.72

e9/l

0.79

568

(3033099) Centromere Ab [Titer] in Serum

183

2.58

8.38

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2742

24809

1.15

8.36

1.5

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

364

2635

1.40

8.34

3.7

3.5

25.36

25.28

mmol/l

0.16

348

2538

(1761868) Lipid panel - Serum or Plasma

3273

35557

0.87

8.32

2.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

749

1.75

8.30

1.2

1.3

74.57

83.62

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

107

3.09

8.22

1.4

1.9

—

(3047181) Lactate [Moles/volume] in Blood

274

1889

1.46

8.22

5.4

6.1

1.28

mmol/l

0.05

239

1650

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

472

1.94

8.13

1.1

—

(3019225) pH of Specimen

731

5880

1.27

8.02

3.8

3.9

7.35

0.04

626

4285

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

450

3393

1.34

8.01

3.3

3.6

1.26

1.34

0.86

450

3373

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

230

2.36

7.98

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

102

553

1.85

7.98

1.4

1.5

6.11

7.19

ug/l

0.83

500

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

112

626

1.80

7.94

2.0

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.14

7.93

1.5

1.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

207

2.42

7.87

1.1

—

290.00

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

773

0.35

7.63

13.6

22.1

1475.26

2645.00

nmol/l

0.46

747

(3026470) Cobalt [Mass/volume] in Blood

273

2.21

7.62

2.2

2.3

3.82

3.35

ug/l

0.20

252

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

748

0.35

7.44

11.3

15.9

774.73

2558.64

nmol/l

0.52

725

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

112

647

1.74

7.15

1.4

1.5

11.91

11.65

umol/l

0.17

107

618

(3047007) Chlamydophila sp Ab [Presence] in Serum

215

1455

1.49

7.13

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

330

2418

1.38

7.09

5.8

5.7

0.83

0.89

1.93

320

2268

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.60

7.04

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1252

0.51

6.99

4.1

5.9

353.33

372.52

umol/l

0.63

1105

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

463

1.87

6.93

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.00

6.90

2.9

11.7

0.60

0.37

umol/l

1.77

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

234

3322

0.70

6.88

1.5

1.13

1.21

ratio

0.65

137

2026

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

234

3322

0.70

6.88

1.5

0.97

0.95

ratio

0.35

137

2012

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

148

2.57

6.83

1.2

1.8

1116.67

8450.00

u/ml

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

234

3312

0.70

6.77

1.5

1.20

1.15

ratio

0.24

137

2001

(3025577) Chromium [Mass/volume] in Blood

269

2.13

6.66

2.3

2.2

2.39

2.59

ug/l

0.16

226

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

277

2.10

6.58

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

178

1180

1.52

6.56

4.9

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

340

2538

1.35

6.53

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

232

3259

0.70

6.44

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

212

1466

1.46

6.36

1.3

4.48

3.85

u/ml

0.30

686

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

113

2.75

6.36

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.73

6.35

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

103

606

1.71

6.22

3.2

2.5

29.37

26.04

mg/l

0.36

417

(3037121) Protein [Mass/volume] in Urine

316

2354

1.36

6.17

3.0

3.7

220.32

406.11

mg/l

3.58

155

1136

(3043238) Trisomy 21 risk [Likelihood] in Fetus

194

2785

0.69

6.11

1.5

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.96

6.09

1.1

1.2

220.00

418.09

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

408

3161

1.30

6.08

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

427

1.83

6.02

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

146

2.47

6.00

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

190

2725

0.69

5.96

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

106

2.74

5.93

2.0

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

497

3962

1.27

5.93

3.6

129.46

131.93

g/l

1.61

482

3862

(3049717) Cytology report of Urine Cyto stain

249

1805

1.39

5.78

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

838

9861

0.83

5.76

1.8

—

7.82

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.07

5.75

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

327

1.93

5.74

1.3

1.6

1.79

3.40

u/field

1.12

244

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

341

1.91

5.74

1.3

1.2

0.30

0.29

g/l

0.63

277

(3005033) Fetal Nuchal fold Thickness US

187

2669

0.69

5.73

1.5

1.29

1.26

0.39

135

1932

(3052592) Norovirus Ag [Presence] in Stool

2.83

5.66

1.5

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2297

20978

1.13

5.64

4.0

4.3

8.31

9.47

mg/mmol

0.40

1473

13326

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

12.87

5.57

1.1

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

261

3505

0.74

5.53

1.5

65.33

61.12

ug/l

0.58

212

2927

(3012516) Albumin [Mass/volume] in Urine

2269

20730

1.13

5.52

3.4

3.6

48.42

49.99

mg/l

0.12

1464

13285

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7768

76126

1.18

5.48

4.9

4.6

4.68

4.74

mmol/l

7.19

7509

72906

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

159

2.33

5.47

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

332

4279

0.77

5.27

1.0

1.1

0.58

0.63

ratio

1.03

451

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

441

0.29

5.26

2.2

2.5

134.77

153.27

nmol/l

0.25

391

(3002256) Pathology report gross observation

1113

9719

1.17

5.23

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

111

700

1.59

5.19

1.2

1.3

0.29

2.10

u/ml

4.19

390

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

291

2203

1.33

5.17

3.5

3.9

2484.42

1340.16

u/ml

0.27

246

1921

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

563

4629

1.23

5.15

2.1

2.2

5.76

7.90

ug/l

2.50

497

4155

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

155

1056

1.48

5.10

1.5

1.4

307.59

357.59

pmol/l

0.69

140

921

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

321

1.88

5.05

1.3

1.2

108.67

108.98

0.03

292

(3010838) Calcium [Moles/time] in 24 hour Urine

194

1382

1.41

5.04

1.7

2.0

5.06

5.33

mmol/24h

0.62

184

1252

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

512

6230

0.81

4.99

1.5

1.6

1011.98

1007.35

mu/l

0.04

429

5253

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

4.69

4.98

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

173

2.20

4.95

1.3

1.7

16.88

47.28

u/l

1.29

160

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

109

697

1.57

4.84

2.6

2.1

31.84

23.60

mg/l

0.65

264

(4035726) Immunohistochemistry procedure

701

5935

1.20

4.77

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

608

5081

1.21

4.75

2.5

2.4

6375.07

6152.17

u/l

0.04

196

2010

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1569

14128

1.13

4.75

2.1

2.2

—

(3020650) Glucose [Presence] in Urine

309

1.85

4.63

1.9

1.5

0.00

0.04

estimate

1.34

309

(3009508) Creatinine [Moles/volume] in Urine

2628

24410

1.11

4.62

3.3

3.6

8.01

8.13

mmol/l

0.61

2314

21327

(3002619) Bacteria identified in Specimen by Culture

192

2.09

4.59

1.4

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

319

2491

1.29

4.57

1.1

7.31

6.08

eliau/ml

0.10

380

(44816559) Phosphatidylethanol [Mass/volume] in Blood

526

4352

1.22

4.56

1.8

0.28

0.30

mg/l

0.61

254

2085

(3046861) Legionella sp Ag [Presence] in Urine

4.52

4.54

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7808

76710

1.16

4.54

5.2

5.1

2.74

2.83

mmol/l

19.81

7523

73193

(3011985) Renin [Units/volume] in Plasma

161

1133

1.43

4.52

1.6

62.09

66.39

mu/l

0.11

152

1034

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1694

15377

1.13

4.49

2.2

2.3

—

(3003181) Sodium [Moles/volume] in Urine

158

1115

1.42

4.38

1.8

1.4

66.96

64.41

mmol/l

0.27

126

887

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

684

7997

0.84

4.38

4.0

4.3

32.56

31.57

1.56

566

5717

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

368

4565

0.80

4.32

1.1

0.88

0.89

g/l

0.33

368

4557

(4268621) Lupus anticoagulant assay

154

1085

1.43

4.32

2.4

2.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

106

693

1.54

4.31

1.3

2.36

1.98

mmol/l

0.68

648

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

189

1380

1.38

4.31

1.1

126.01

115.99

4.06

172

1269

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

199

1470

1.36

4.23

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

241

1.91

4.18

1.6

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

241

1.91

4.18

1.6

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

175

1270

1.39

4.16

3.7

3.8

171.06

695.17

u/ml

1.35

152

1157

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

242

1.91

4.14

1.6

2.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7038

68773

1.12

4.12

38.2

16.3

331.71

333.37

g/l

46.49

7020

68437

(3018405) Lactate [Moles/volume] in Arterial blood

252

1937

1.31

4.10

3.5

4.0

1.28

1.38

mmol/l

0.99

245

1908

(44813793) Dust mix specific IgE antibody measurement

100

656

1.53

4.03

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7715

75832

1.14

4.01

4.7

4.5

1.49

1.45

mmol/l

12.88

7448

72323

(3050129) First trimester maternal screen panel - Serum or Plasma

331

4118

0.80

4.01

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

286

2246

1.28

3.97

1.3

1.5

657.99

498.72

mg/l

0.62

271

2153

(3016135) IgD [Mass/volume] in Serum

5.56

3.97

1.4

1.3

94.00

41.79

mg/l

—

(3036489) Thrombin time

390

3177

1.24

3.97

2.3

2.4

20.60

20.81

0.22

331

2772

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

470

1.62

3.95

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

441

1.64

3.89

1.4

1.9

1.71

u/field

0.00

247

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

442

1.63

3.86

1.2

1.3

52.25

72.10

—

(3050794) Legionella sp Ab [Presence] in Serum

2.77

3.84

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

187

1391

1.35

3.84

1.4

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

214

1.92

3.80

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

253

1969

1.29

3.79

1.4

1.5

84.26

26.94

e6/l

0.62

191

1428

(4195642) Thrombophilia screening test

185

1378

1.35

3.77

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

376

1.68

3.77

1.2

1.1

—

0.13

—

(40768793) Breast Pathology biopsy report

134

1872

0.71

3.76

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

256

2000

1.29

3.73

1.5

1.6

4019.42

3253.85

e6/l

0.09

206

1551

(3022313) Gas panel - Capillary blood

368

3003

1.24

3.71

3.4

3.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

679

0.53

3.70

10.0

13.3

0.60

0.61

mmol/l

0.02

621

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

304

1.75

3.66

1.3

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

304

1.75

3.66

1.3

1.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

556

0.48

3.64

1.1

—

(3016038) Potassium [Moles/volume] in Urine

419

1.63

3.62

1.7

1.3

34.74

35.61

mmol/l

0.09

380

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

254

1992

1.28

3.60

1.3

1.4

3.54

3.68

mmol/l

1.56

231

1894

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

317

2554

1.25

3.59

1.2

4.40

4.09

0.31

437

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

405

1.63

3.57

1.1

1.2

1335.71

1033.75

titre

1.12

(3001019) Free T4 and TSH panel - Serum or Plasma

463

5493

0.83

3.54

1.6

1.7

—

(3006270) Folate [Moles/volume] in Blood

500

1.57

3.53

1.1

386.53

393.49

nmol/l

0.12

461

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

301

2424

1.25

3.44

3.2

3.9

24.61

24.71

mmol/l

0.34

284

2277

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.08

3.39

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

342

1.67

3.38

1.8

2.7

0.19

0.20

e9/l

0.12

170

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

343

2809

1.23

3.37

2.5

2.6

96.03

95.10

0.32

328

2713

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.92

3.29

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

106

737

1.44

3.29

1.5

1.4

1.60

1.45

nmol/l

0.75

669

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.47

3.29

1.1

1.2

0.31

0.69

iu/ml

—

(3039000) Anion gap in Blood by calculation

167

1254

1.34

3.28

7.1

7.6

11.12

11.39

mmol/l

0.57

156

1117

(3018572) Chloride [Moles/volume] in Blood

167

1255

1.34

3.27

7.1

7.6

105.21

105.23

mmol/l

0.01

156

1118

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

0.62

0.93

mg/l

0.43

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

0.91

2.22

mg/l

1.18

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

7.75

4.79

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

2.85

1.95

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

2.96

1.18

mg/l

0.39

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

3.14

2.48

mg/l

0.16

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

1.14

1.31

mg/l

0.09

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.38

3.22

1.5

1.6

2.26

2.21

mg/l

0.01

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.58

3.20

1.0

—

3.40

—

(3017569) Oxygen content in Arterial blood

295

1.70

3.18

2.3

2.4

16.52

16.46

0.05

295

(3034274) Bile acid [Moles/volume] in Serum --fasting

201

1558

1.30

3.17

2.2

2.4

6.30

6.61

umol/l

0.14

148

1152

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

274

1.72

3.12

2.6

2.7

0.60

0.61

mmol/l

0.71

274

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

208

1.83

3.11

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

115

821

1.41

3.11

1.4

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

155

1162

1.34

3.10

1.2

1.3

0.18

0.25

nmol/l

0.46

(4198724) Urine methamphetamine measurement

640

0.56

3.09

2.1

2.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

408

1.57

3.02

1.5

1.3

147.61

163.45

mmol/24h

0.87

408

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

203

1.83

3.02

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

686

1.43

2.97

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

106

754

1.41

2.95

2.3

2.6

1.74

1.37

g/24h

0.35

455

(3028707) Methadone [Presence] in Urine by Screen method

199

2524

0.78

2.94

2.2

3.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

141

1052

1.35

2.93

1.1

98.28

97.62

0.10

134

996

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

312

2572

1.22

2.93

3.1

3.62

3.53

g/l

0.48

294

2459

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.28

2.93

1.5

1.6

0.71

1.67

mg/l

0.80

(4281824) Cell count and differential, peritoneal fluid

789

0.62

2.89

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

134

1787

0.75

2.89

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.21

2.89

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.09

2.88

1.1

1.0

278.44

274.91

u/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

320

1.63

2.85

1.3

6.3

6799.27

68.43

mg/l

0.79

243

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

313

2589

1.22

2.85

2.7

2.8

188.31

180.41

0.84

297

2479

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

530

0.55

2.78

1.2

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1357

0.72

2.72

1.7

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.24

2.69

1.2

1.0

0.02

0.03

u/ml

0.23

(3047189) Immunofixation for 24 hour Urine

243

1.69

2.62

1.5

1.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

515

1.46

2.56

1.5

1.4

74.83

76.87

umol/l

0.33

515

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

143

1.89

2.50

2.3

3.1

46.61

32.12

mg/l

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

134

1020

1.32

2.49

1.1

—

16.03

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

610

1.41

2.49

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

2.98

2.48

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

168

1319

1.28

2.48

3.3

2.7

1.31

1.48

mmol/l

2.90

163

1275

(3004451) EKG impression Narrative

317

1.58

2.48

1.5

1.3

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

4.38

2.47

1.3

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.20

2.47

1.3

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

671

1.39

2.44

1.3

1.2

109.10

116.23

pmol/l

0.94

671

(3016330) Potassium [Moles/time] in 24 hour Urine

103

2.04

2.41

1.5

1.4

—

97.62

—

(21494434) Karyotype in Bone marrow

531

1.44

2.40

1.1

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.34

2.39

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

125

1.92

2.34

1.2

0.58

158.56

mg/l

1.72

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

109

814

1.34

2.33

1.1

241.35

251.80

mg/l

0.20

736

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

632

5633

1.13

2.31

1.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7141

70306

1.08

2.29

5.4

37.37

38.13

mmol/mol

11.42

6885

67184

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

301

1.56

2.26

1.1

1.2

98.18

90.49

0.72

134

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

951

10393

0.90

2.26

2.5

2.7

0.66

0.68

ug/l

0.41

537

5609

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

3.89

2.25

1.3

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.89

2.25

1.3

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

278

1.59

2.24

1.1

1.2

30.00

13.00

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

2.24

0.0

1.4

—

29.99

—

(3018291) Platelet Ab [Presence] in Serum

5.56

2.21

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.56

2.21

1.6

1.0

290.20

260.33

nmol/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

311

1.55

2.20

2.0

2.3

7.38

8.08

mmol/l

0.85

311

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

111

840

1.33

2.19

1.2

44.77

40.32

mg/l

0.39

722

(3000034) Microalbumin [Mass/volume] in Urine

567

1.40

2.18

2.9

44.26

62.82

mg/l

0.42

406

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

312

1.54

2.18

1.1

100.50

92.06

1.17

140

(3040151) Glucose [Moles/volume] in Capillary blood

729

1.35

2.17

3.1

5.0

6.98

7.15

mmol/l

0.21

616

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

217

1785

1.22

2.17

3.5

4.0

0.35

0.34

iu/ml

0.12

108

933

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.00

2.14

1.2

1.0

0.05

0.04

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

259

2172

1.20

2.13

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

168

0.36

2.12

1.0

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

126

976

1.30

2.12

1.2

1.3

0.19

0.20

nmol/l

0.17

762

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.37

2.12

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

152

1.78

2.11

1.8

2.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

259

2175

1.20

2.11

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

364

4198

0.86

2.09

2.0

3.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

128

997

1.29

2.07

1.6

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

229

1.62

2.07

1.7

1.9

39.45

40.82

g/l

0.78

229

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

5.00

2.07

1.0

1.20

1.50

u/field

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

117

901

1.30

2.06

1.1

1.2

23.33

30.71

nmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

577

5161

1.13

2.03

1.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

319

1.51

1.99

1.2

117.05

109.76

0.54

294

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

561

1.38

1.98

2.5

2.6

103.75

97.56

0.74

529

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

201

1.64

1.98

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

502

1.40

1.97

1.4

5.44

6.10

mmol/l

1.03

468

(3000764) Benzodiazepines [Presence] in Urine

540

6036

0.89

1.96

1.7

2.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

119

1.85

1.96

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

217

1.62

1.96

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

211

1754

1.21

1.94

1.6

1.8

—

(3033086) Enterovirus Ab [Titer] in Serum

2.96

1.93

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.96

1.93

1.5

1.2

31.83

30.26

mg/24h

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.75

1.93

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

101

771

1.31

1.92

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

106

1.89

1.90

1.3

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

150

1.74

1.90

1.1

—

(3028300) Cannabinoids [Presence] in Urine

547

6084

0.89

1.84

1.7

2.2

—

(3027944) Amphetamines [Presence] in Urine

539

5999

0.89

1.84

1.7

2.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

122

1.81

1.83

1.0

1.5

—

132.62

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

167

1.68

1.83

1.5

0.39

0.24

mmol/l

—

(4146454) Self-monitoring of blood glucose

611

0.67

1.82

2.8

2.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

453

0.62

1.81

2.0

7.4

—

7187.40

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

545

1.36

1.80

1.6

1.8

2.78

3.78

mg/l

3.35

530

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

238

1.56

1.80

1.4

1.3

101.66

125.04

nmol/l

0.56

174

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

235

0.47

1.80

1.0

1.1

0.19

8.91

u/ml

—

160

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

207

1.60

1.79

1.1

1.2

76.80

83.18

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.76

1.79

2.6

3.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

369

1.44

1.78

1.1

134.35

244.82

ng/l

0.52

(3027008) Opiates [Presence] in Urine

547

6070

0.89

1.78

1.7

2.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

420

4733

0.88

1.77

1.8

2.3

—

(3006653) Thiamine [Moles/volume] in Blood

420

1.41

1.76

1.3

1.4

132.71

134.95

nmol/l

0.18

420

(3006462) Nitrate [Presence] in Urine

289

1.49

1.73

3.1

2.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

218

1.56

1.70

1.1

1.5

104.76

104.18

0.04

207

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

332

0.57

1.68

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

196

1.58

1.65

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

205

1.56

1.61

1.1

63.56

70.04

—

(4211845) Urine protein measurement

319

1.44

1.61

3.0

2.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

118

946

1.25

1.59

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

173

1447

1.20

1.55

1.1

2.01

3.50

eliau/ml

2.62

758

(3016879) Cocaine [Presence] in Urine

510

5630

0.90

1.54

1.7

2.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

1.54

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.97

1.53

1.4

4.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

457

0.66

1.53

1.0

—

(3035880) pH of Pleural fluid

225

1.51

1.3

7.38

7.39

0.10

150

(3051339) Copper [Moles/volume] in Blood

2.04

1.43

1.2

15.54

16.42

umol/l

0.26

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.79

1.42

2.4

2.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

283

2484

1.14

1.42

1.6

1.4

—

(40768800) Prostate Pathology biopsy report

853

0.76

1.42

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

796

0.75

1.41

1.4

1.3

153.24

191.52

pmol/l

1.45

796

(44806071) Cardiolipin IgM antibody measurement

141

1.63

1.41

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

399

0.65

1.40

1.0

260.81

311.16

ng/l

1.32

299

(40761995) Spermatozoa Progressive [#/volume] in Semen

397

0.65

1.37

3.3

41.12

44.55

0.36

397

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

399

1.36

1.1

88.98

94.11

0.90

326

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

396

0.66

1.36

6.6

10.81

8.55

1.00

396

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

101

813

1.25

1.36

1.1

21.63

17.41

u/ml

0.47

355

(4027681) Cerebrospinal fluid IgG ratio and IgG index

644

1.28

1.35

1.3

1.2

0.58

0.65

ratio

0.88

391

(3024928) Oxygen saturation in Venous blood

204

1758

1.16

1.34

3.1

4.0

63.61

63.67

0.01

198

1712

(3008295) Osmolality of Serum or Plasma

781

1.24

1.31

1.6

276.40

281.14

mosm/kgh2o

1.37

608

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

485

0.70

1.28

1.6

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.78

1.28

3.0

1.4

1.74

2.27

mmol/24h

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

508

1.30

1.28

2.6

2.2

1.19

1.20

mmol/l

0.56

501

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

147

1738

0.84

1.27

1.2

1.4

3.01

3.77

ug/l

1.25

134

1571

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

413

1.33

1.27

1.7

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

401

0.67

1.26

1.0

33.95

40.88

ng/l

0.95

294

(3041354) Potassium [Moles/volume] in Venous blood

527

1.29

1.26

2.5

2.2

3.92

4.01

mmol/l

0.94

520

(3035285) Chloride [Moles/volume] in Venous blood

527

1.29

1.26

2.5

2.2

106.06

105.45

mmol/l

0.52

520

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

399

0.68

1.24

1.0

791.19

789.27

ng/l

0.01

289

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

123

1.63

1.23

1.1

1.0

0.15

0.02

u/ml

0.40

(3044009) aPTT.lupus sensitive (LA screen)

1.77

1.22

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

108

1.67

1.22

1.3

1.7

—

(3003129) Base excess in Capillary blood by calculation

735

1.24

1.21

2.7

2.0

1.10

0.45

mmol/l

0.86

706

(3001218) Citrate [Mass/time] in 24 hour Urine

2.63

1.21

2.6

1.5

262.80

423.37

mg/24h

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

189

1.48

1.18

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

410

1.32

1.17

1.1

—

(3045788) Cell count panel - Pleural fluid

463

1.30

1.17

1.5

—

(40758292) HTLV I+II Ab panel - Serum

186

0.54

1.16

1.2

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

421

1.31

1.14

1.6

2.4

162.94

135.50

umol/l

0.16

215

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.90

1.12

1.0

1.2

—

(40762814) Titanium [Mass/volume] in Blood

1.78

1.10

2.6

2.4

4.67

4.66

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1587

15210

1.05

1.10

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

831

0.79

1.10

1.5

—

(3017400) Magnesium [Moles/volume] in Urine

2.38

1.09

1.4

1.0

3.19

2.98

mmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1203

12632

0.94

1.08

1.7

1.8

1.46

1.41

1.94

1054

11343

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.19

1.08

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1291

13523

0.95

1.06

3.2

3.6

22.98

21.45

2.29

509

5233

(3026250) Tacrolimus [Mass/volume] in Blood

478

0.73

1.06

44.0

42.2

7.12

7.41

ug/l

0.43

440

(3012441) Differential panel - Pleural fluid

479

1.28

1.06

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

121

1.57

1.05

1.2

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7264

71993

1.05

4.1

3.9

1.31

1.29

mmol/l

0.83

6986

68274

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

368

3357

1.10

1.03

1.6

1.7

12.59

12.26

u/ml

0.03

946

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.02

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

652

1.23

1.02

1.7

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

143

1230

1.17

1.02

2.3

2.5

12.01

28.34

iu/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.83

1.02

1.6

2.3

0.36

0.67

u/field

0.87

(3025018) Bordetella pertussis Ab [Titer] in Serum

725

1.22

1.02

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

169

1473

1.15

1.02

1.1

62.46

7752.28

iu/ml

0.64

349

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

286

2579

1.11

1.01

1.8

2.0

199.55

207.62

pmol/l

0.71

275

2471

(3023199) Leukocytes [#/volume] in Pleural fluid

555

1.25

1.00

1.5

7330.73

3811.78

e6/l

0.60

383

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

733

6891

1.07

0.99

1.2

105.43

143.97

u/ml

1.94

268

2652

(3011897) Casein IgE Ab [Units/volume] in Serum

214

1.40

0.99

1.1

1.2

0.09

3.23

u/ml

0.76

214

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

390

4244

0.92

0.97

2.1

3.3

38.66

47.58

u/ml

0.56

375

4117

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

397

1.29

0.97

1.6

2.0

91.56

101.83

ng/l

0.35

397

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.96

0.0

1.1

—

(1002224) Polysomnography panel

542

5051

1.08

0.95

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

210

0.62

0.94

1.1

1.9

0.22

0.23

nmol/l

—

160

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

270

0.67

0.94

1.3

2.3

13.59

16.11

umol/l

0.59

270

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.65

0.94

1.1

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.82

0.92

1.6

1.5

304.30

324.65

umol/24h

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

580

1.23

0.92

1.2

1.1

1.22

1.10

u/l

0.45

230

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.07

0.89

1.0

2.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

662

0.80

0.88

1.5

2.2

14.01

24.86

ug/l

3.88

649

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.65

0.87

1.5

1.3

1.87

2.06

mmol/l

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

706

0.81

0.87

1.4

34.53

35.78

nmol/l

0.11

636

(3025130) Human papilloma virus identified in Specimen

181

1606

1.13

0.87

2.0

1.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.86

0.87

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

239

2643

0.90

0.86

1.1

0.53

2.24

u/ml

11.46

126

1416

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.76

0.83

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.76

0.83

2.2

6.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.88

0.81

1.0

1.1

0.01

1.79

u/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

162

1821

0.89

0.79

1.0

1.1

4.68

5.56

u/ml

0.27

829

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

729

0.82

0.79

1.3

1.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.79

0.0

6.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

630

5950

1.06

0.78

3.3

4.5

65.12

25.68

ug/l

0.67

469

4660

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.51

0.77

1.0

1.1

0.08

0.31

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.77

0.0

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

200

1804

1.11

0.76

1.2

1.1

27.81

14.50

au/ml

1.08

512

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

14.96

—

(44806420) Estimation of glomerular filtration rate

118

1030

1.15

0.76

2.7

2.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

200

1.35

0.76

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

124

1.45

0.75

3.6

6.0

43.73

41.69

ug/min

0.05

(3028308) Erythrocytes [#/volume] in Pleural fluid

478

1.21

0.73

1.6

1.5

51712.11

73909.41

e6/l

0.36

258

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.80

0.72

1.4

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.61

0.72

1.3

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

203

2233

0.91

0.70

1.1

1.55

1.99

u/ml

0.42

111

1152

(3014271) Vancomycin [Susceptibility]

178

1.35

0.68

2.9

2.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.68

1.7

5.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

419

1.22

0.68

1.5

1.3

777.61

413.42

u/l

1.61

402

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

117

0.60

0.67

1.1

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

238

0.71

0.67

1.5

2.8

133.77

120.27

ng/l

0.14

141

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7217

71697

1.04

0.66

4.1

4.4

5.71

5.78

mmol/l

6.01

6862

67565

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

1942

0.90

0.66

1.1

4.84

4.37

u/ml

0.12

988

(40768795) Lymph node Pathology biopsy report

745

0.84

0.66

1.1

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

145

1.38

0.65

1.9

3.3

16.60

29.52

ug/l

0.20

145

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.59

0.65

1.0

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

129

1.40

0.63

1.2

1.1

0.77

0.69

umol/24h

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.52

0.62

1.0

1.1

64.00

88.71

titre

1.22

(3043410) Blood group antigens tested for on Red Blood Cells

199

1.31

0.62

2.5

1.6

—

(4038314) Semen analysis, post vasectomy

104

0.58

0.61

1.5

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

152

0.66

0.61

5.2

2.5

2.70

1.65

mmol/l

—

115

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

813

0.86

0.60

2.0

2.6

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.0

—

9630.33

—

(3042733) HLA Ab [Presence] in Serum

344

0.78

0.59

3.9

5.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

6.1

—

0.25

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.58

0.0

1.1

—

33.58

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

753

1.14

0.58

1.1

12.53

8.01

iu/ml

0.32

213

(3019174) dRVVT (LA screen)

1.46

0.57

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

144

1590

0.90

0.57

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.48

0.57

1.4

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

328

1.22

0.57

1.3

86.66

241.33

nmol/24h

0.94

328

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

319

1.22

0.56

1.2

1.1

—

(3024932) HLA-DR beta [Type]

297

0.77

0.56

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5872

58211

1.03

0.55

4.0

3.3

49.10

42.25

u/l

7.39

5651

55805

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

194

1.29

0.55

4.7

4.6

10.89

10.49

kpa

0.55

194

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

194

1.29

0.55

4.7

4.6

4.85

4.98

kpa

0.18

194

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

182

1976

0.92

0.52

1.5

0.32

0.41

nmol/l

2.01

134

1528

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

181

0.72

0.52

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

151

1653

0.91

0.52

1.0

1.1

0.17

0.50

u/ml

1.38

517

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.50

0.51

1.0

1.3

15.00

2007.74

u/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

714

0.87

0.50

1.0

0.14

1.04

u/ml

1.27

173

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.46

0.50

1.0

8.88

8.44

mmol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

153

1.31

0.50

1.3

1.4

1.17

1.18

mmol/l

0.40

153

(4094501) Cardiovascular stress test using bicycle ergometer

223

2075

1.08

0.50

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

190

0.74

0.49

1.4

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

189

0.74

0.48

2.5

6.7

—

3141.41

—

(3023183) Ammonium ion [Moles/volume] in Plasma

168

1549

1.09

0.48

3.3

3.1

32.70

35.12

umol/l

0.52

153

1440

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

376

0.82

0.47

1.1

1.2

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

163

1503

1.09

0.47

3.4

2.4

13.35

13.09

2.29

163

1485

(3012494) Peanut IgE Ab [Units/volume] in Serum

300

1.20

0.46

1.0

1.1

0.14

5.99

u/ml

1.50

179

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

148

1609

0.92

0.46

1.9

2.5

1.06

0.84

nmol/l

3.30

131

1382

(3008401) Mugwort IgE Ab [Units/volume] in Serum

208

2229

0.93

0.45

1.1

0.63

1.27

u/ml

2.14

1011

(3004775) Volume in Urine collected for unspecified duration

461

0.85

0.45

1.7

2.4

848.07

633.58

1.73

335

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

779

1.12

0.45

1.9

3.2

3.61

11.77

nmol/l

0.60

752

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

210

1.24

0.44

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

210

1.24

0.44

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

210

1.24

0.44

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

128

1397

0.92

0.44

2.3

2.5

86.97

113.88

ug/min

0.42

892

(3003888) Timothy IgE Ab [Units/volume] in Serum

217

2318

0.93

0.44

1.1

4.10

6.19

u/ml

1.32

113

1292

(3018001) Oat IgE Ab [Units/volume] in Serum

1.41

0.43

1.0

0.04

0.25

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.42

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

103

937

1.10

0.41

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

661

1.12

0.41

3.1

3.2

0.78

0.80

nmol/l

0.14

523

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

228

0.79

0.41

1.2

1.3

68.22

69.62

ug/l

0.04

228

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.40

0.0

2.4

—

27.68

—

(40768446) Kidney Pathology biopsy report

380

1.16

0.40

1.4

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

149

0.74

0.40

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

191

1790

1.07

0.39

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.38

0.38

2.7

3.0

0.72

1.48

mg/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

159

0.75

0.38

9.8

7.0

6.66

5.48

kpa

0.64

159

(3005532) Lymphocytes/Leukocytes in Pleural fluid

159

0.75

0.38

1.4

1.5

39.75

58.28

0.87

134

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

277

2916

0.95

0.37

1.6

—

(3024471) HLA-A [Type]

301

0.83

0.37

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.35

0.37

12.6

9.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

591

1.12

0.36

2.2

2.7

—

(3034426) Prothrombin time (PT)

318

1.16

0.36

1.3

1.2

28.43

28.56

0.05

318

(3023487) Leukocytes [#/volume] in Peritoneal fluid

245

0.82

0.35

2.2

2.3

289.82

929.42

e6/l

2.37

175

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.35

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.66

0.35

1.0

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.65

0.35

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

588

5689

1.04

0.35

3.0

3.6

4.56

4.57

pmol/l

0.05

545

5185

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

498

1.13

0.35

1.1

8.42

4.64

nmol/l

—

(4212803) Bone marrow aspirate examination

1.40

0.35

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

788

7669

1.03

0.34

2.0

2.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

216

2278

0.95

0.33

1.5

57.25

59.24

ug/l

0.32

216

2278

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.68

0.33

1.0

1.1

0.99

1.31

mom

—

(3023410) Appearance of Cerebral spinal fluid

103

952

1.08

0.32

1.7

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

493

1.12

0.31

1.6

1.5

0.53

0.51

e9/l

0.30

493

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

174

1.21

0.31

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

353

3395

1.04

0.31

1.6

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

348

3346

1.04

0.31

1.6

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

314

0.86

0.29

1.2

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

125

1170

1.07

0.29

1.3

27.67

30.19

u/l

0.14

120

1020

(3016750) Collection duration of Urine

367

0.87

0.29

1.9

2.3

525.22

496.93

min

0.93

288

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

756

7378

1.03

0.29

6.3

5.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.23

0.29

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.23

0.29

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

117

1249

0.94

0.28

1.5

1.4

7.22

6.96

mmol/l

0.39

111

1133

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.1

—

(40768806) Pleura Pathology biopsy report

470

1.11

0.27

1.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.23

0.27

1.1

1.2

—

577.53

—

(3045142) Bone marrow Pathology biopsy report

723

1.08

0.25

1.3

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.22

0.25

3.8

6.6

13.36

8.12

mmol/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.22

0.25

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

177

1687

1.05

0.25

1.3

1.4

22.22

24.41

u/l

0.49

153

1382

(3014599) Egg white IgE Ab [Units/volume] in Serum

756

0.93

0.24

1.0

1.1

0.68

2.70

u/ml

1.50

184

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.28

0.24

1.6

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

373

3617

1.03

0.23

1.3

1.5

9.50

8.98

u/l

0.30

304

2899

(3026692) Albumin [Mass/volume] in Peritoneal fluid

179

0.84

0.23

1.4

1.5

10.43

12.53

g/l

—

132

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

168

0.83

0.22

1.0

1.1

3.02

6.51

u/ml

1.12

168

(44786800) Granulocytes/Leukocytes in Body fluid

1.25

0.22

1.2

1.3

32.20

33.58

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

239

2479

0.96

0.22

1.6

2.1

2.88

5.97

iu/l

0.83

1110

(3020491) Glucose [Moles/volume] in Blood

545

1.08

0.21

2.0

1.7

7.25

6.33

mmol/l

1.40

406

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

534

0.92

0.21

1.6

1.9

4.03

2.34

u/ml

0.33

167

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

124

0.81

0.21

1.2

1.0

0.53

0.58

u/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

336

3462

0.97

0.21

2.0

1.9

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1667.00

—

(3032868) Hemoglobin electrophoresis panel in Blood

105

0.76

0.21

1.5

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.1

—

168.92

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

134

0.82

0.20

1.5

2.29

3.31

0.36

115

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

644

1.07

0.20

1.5

2.0

287.10

1362.93

pmol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

108

1.20

0.20

1.3

1.2

1.40

98.89

ug/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.20

0.19

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.21

0.19

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

260

0.88

0.19

1.3

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

539

1.08

0.19

1.2

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

146

1.16

0.19

1.2

1.8

3.83

2.15

ug/l

0.30

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.13

0.18

1.0

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

455

1.08

0.17

1.7

2.95

9.84

nmol/l

0.64

359

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

131

0.84

0.17

1.0

0.92

0.36

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.76

0.17

1.4

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.75

0.17

1.4

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

572

5617

1.02

0.16

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.16

0.16

1.4

1.2

1.44

1.74

umol/24h

—

(3001556) Androgen free Index in Serum or Plasma

141

0.85

0.16

1.3

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

401

0.92

0.16

1.1

1.0

10.71

12.49

u/ml

0.22

273

(3023383) Lactate [Moles/volume] in Pleural fluid

130

1.15

0.15

1.5

1.3

4.15

3.51

mmol/l

0.28

116

(4133840) Spirometry

245

0.90

0.15

1.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

608

6178

0.98

0.15

1.4

24.67

24.96

iu/l

0.08

526

5228

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

155

1498

1.04

0.15

1.4

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.83

0.13

3.0

3.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

109

0.83

0.13

1.4

1.2

6.77

5.67

mmol/l

—

109

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

161

1.12

0.13

1.1

1.0

77.39

77.89

ug/l

0.02

139

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

499

0.94

0.13

5.4

7.4

34.84

92.00

ug/l

0.63

335

(3017509) Phencyclidine [Presence] in Urine

148

0.88

0.12

1.2

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

668

1.05

0.12

1.4

1.3

4.41

5.55

umol/l

1.94

595

(3044007) Cell count panel - Peritoneal fluid

210

0.90

0.12

2.3

2.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

116

0.86

0.12

3.2

6.7

11.89

10.72

—

116

(3051387) C reactive protein [Mass/volume] in Capillary blood

135

1387

0.97

0.10

4.0

3.2

26.20

24.88

mg/l

0.18

101

915

(3021387) Prolactin [Units/volume] in Serum or Plasma

437

4430

0.99

0.10

1.6

1.7

273.09

298.40

mu/l

1.01

396

4019

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

207

0.92

0.09

1.9

545.67

14022.44

e6/l

—

108

(3014891) Appearance of Pleural fluid

1.06

0.09

1.0

1.6

—

(4015189) Microbial culture of sputum

116

1.12

0.09

3.2

2.4

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

124

0.89

0.09

1.5

37.92

28.96

0.35

114

(3019832) Treponema pallidum Ab [Presence] in Serum

1285

12933

0.99

0.08

1.7

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

247

0.93

0.08

2.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1719

17099

1.01

0.08

3.9

4.3

1.75

1.89

ug/l

0.74

1599

15767

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

283

1.06

0.08

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

1.04

0.08

1.3

5.8

—

(3011048) Pyruvate [Moles/volume] in Blood

1.07

0.07

1.7

1.3

89.00

86.72

umol/l

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

153

0.91

0.07

1.4

18.40

24.86

g/l

—

109

(3027923) C peptide [Moles/volume] in Serum or Plasma

438

0.96

0.07

1.5

1.7

1.28

1.32

nmol/l

0.09

331

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.06

0.07

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

472

1.04

0.06

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

138

1.09

0.06

1.3

1.2

58.60

65.64

ug/l

0.56

138

(3020191) Ethanol [Moles/volume] in Serum or Plasma

810

0.98

0.06

1.2

1.6

1.01

1.31

promille

1.19

631

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

135

1374

0.98

0.06

1.4

1.6

424.46

365.65

mu/l

0.33

114

1095

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

842

1.02

0.05

3.6

5.2

96.34

74.93

u/ml

0.12

279

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

919

9224

1.00

0.03

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

764

0.98

0.03

1.0

1.1

0.36

2.03

u/ml

2.18

244

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

102

1.08

0.03

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

172

1.05

0.02

2.1

2.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

389

0.98

0.02

2.0

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

103

1.07

0.02

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

338

0.98

0.01

3.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

1.06

0.01

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

104

1.06

0.01

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

754

7549

1.00

0.00

2.3

2.4

13.23

13.36

nmol/l

0.19

701

6991

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

164

1.04

0.00

1.1

1.2

4.89

12.01

pmol/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

196

0.97

0.00

1.4

2.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.03

0.00

1.6

1.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

267

1.01

0.00

1.9

2.1

102.43

123.85

ug/min

—

(3024869) Neuronal Ab [Presence] in Serum

112

0.98

0.00

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

228

1.01

0.00

1.1

50.35

34.63

iu/ml

0.47

228

(40765096) Chromosome analysis panel by Banding

219

1.00

0.00

1.0

1.1

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.8

—

1.60

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

3.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

0.61

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.8

—

0.06

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.98

-0.00

1.7

1.2

0.15

0.17

umol/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.00

-0.00

1.3

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.9

—

10.44

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.85

-0.00

1.0

1.1

2.80

14.86

u/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.01

-0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_RHEUMA_BIOLOGICAL and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_RHEUMA_BIOLOGICAL	1.215 [1.03, 1.43]	0.02
Birth year	0.995 [0.99, 1.0]	0.23

During the follow-up period (1.1.1998 — 31.12.2019), 412 out of 12676 females with RX_RHEUMA_BIOLOGICAL died.

Males

Parameter	HR [95% CI]	p-value
RX_RHEUMA_BIOLOGICAL	1.05 [0.89, 1.24]	0.563
Birth year	0.989 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 404 out of 9858 males with RX_RHEUMA_BIOLOGICAL died.

Mortality risk

Mortality risk for people of age

years, who have RX_RHEUMA_BIOLOGICAL.

N-year risk	Females	Males
1	0.084%	0.15%
5	0.616%	1.265%
10	1.714%	3.156%
15	3.288%	6.052%
20	6.051%	10.247%

Relationships between endpoints

↥

Index endpoint: RX_RHEUMA_BIOLOGICAL – Biological medication for rheuma

GWS hits: 13

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Biological medication for rheuma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints